<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">100159</article-id><article-id pub-id-type="doi">10.7554/eLife.100159</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.100159.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title><italic>Eed</italic> controls craniofacial osteoblast differentiation and mesenchymal proliferation from the neural crest</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Casey-Clyde</surname><given-names>Tim</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>S John</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Pelonero</surname><given-names>Angelo</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Serrano</surname><given-names>Juan Antonio Camara</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Teng</surname><given-names>Camilla</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jang</surname><given-names>Yoon-Gu</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Vasudevan</surname><given-names>Harish N</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Padmanabhan</surname><given-names>Arun</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bush</surname><given-names>Jeffrey Ohmann</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6053-8756</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Raleigh</surname><given-names>David R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9299-8864</contrib-id><email>david.raleigh@ucsf.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Radiation Oncology, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Neurosurgery, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Pathology, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/038321296</institution-id><institution>Gladstone Institutes</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/038321296</institution-id><institution>Roddenberry Center for Stem Cell Biology at Gladstone Institutes</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05yndxy10</institution-id><institution>Helen Diller Family Comprehensive Cancer Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Cell and Tissue Biology, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Medicine, Division of Cardiology, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Cardiovascular Resarch Institute, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chen</surname><given-names>Di</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>Chinese Academy of Sciences</institution></institution-wrap><country>China</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cheah</surname><given-names>Kathryn Song Eng</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02zhqgq86</institution-id><institution>University of Hong Kong</institution></institution-wrap><country>Hong Kong</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>02</day><month>12</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP100159</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-07-11"><day>11</day><month>07</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-07-12"><day>12</day><month>07</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.03.13.584903"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-11-22"><day>22</day><month>11</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100159.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-11-17"><day>17</day><month>11</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100159.2"/></event></pub-history><permissions><copyright-statement>© 2024, Casey-Clyde et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Casey-Clyde et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-100159-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-100159-figures-v1.pdf"/><abstract><p> The histone methyltransferase Polycomb repressive complex 2 (PRC2) is required for specification of the neural crest, and mis-regulation of neural crest development can cause severe congenital malformations. PRC2 is necessary for neural crest induction, but the embryonic, cellular, and molecular consequences of PRC2 activity after neural crest induction are incompletely understood. Here, we show that <italic>Eed</italic>, which encodes a protein that is a core subunit of PRC2, is required for craniofacial osteoblast differentiation and mesenchymal proliferation after induction of the neural crest. Integrating mouse genetics with single-cell RNA sequencing and epigenetic profiling, our results reveal that conditional knockout of <italic>Eed</italic> after neural crest cell induction causes severe craniofacial hypoplasia, impaired craniofacial osteogenesis, and attenuated craniofacial mesenchymal cell proliferation that is first evident in post-migratory neural crest cell populations. We show that <italic>Eed</italic> drives mesenchymal differentiation and proliferation in vivo and in primary craniofacial cell cultures by epigenetically regulating diverse transcription factor programs that are required for specification of post-migratory neural crest cells. These data enhance understanding of epigenetic mechanisms that underlie craniofacial development and shed light on the embryonic, cellular, and molecular drivers of rare congenital syndromes in humans.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>craniofacial development</kwd><kwd>single-cell sequencing</kwd><kwd>chromatin</kwd><kwd>epigenetics</kwd><kwd>osteoblasts</kwd><kwd>mesenchymal</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 CA151022</award-id><principal-award-recipient><name><surname>Casey-Clyde</surname><given-names>Tim</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35 DE031926</award-id><principal-award-recipient><name><surname>Bush</surname><given-names>Jeffrey Ohmann</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R21 HD106238</award-id><principal-award-recipient><name><surname>Raleigh</surname><given-names>David R</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042tbn311</institution-id><institution>Department of Defence</institution></institution-wrap></funding-source><award-id>NFRP NF200021</award-id><principal-award-recipient><name><surname>Raleigh</surname><given-names>David R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Eed, a core subunit of Polycomb repressive complex 2, is required for craniofacial osteoblast differentiation and mesenchymal proliferation after induction of the neural crest.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The embryonic neural crest is a multipotent progenitor cell population that gives rise to peripheral neurons, glia, Schwann cells, melanocytes, and diverse mesenchymal cells such as osteoblasts, chondrocytes, fibroblasts, cardiac mesenchyme, and cardiomyocytes (<xref ref-type="bibr" rid="bib4">Bronner and LeDouarin, 2012</xref>; <xref ref-type="bibr" rid="bib74">Simões-Costa and Bronner, 2015</xref>). Following induction in the neural tube, cranial neural crest cells undergo dorsolateral migration to the pharyngeal arches and differentiate to form craniofacial bones and cartilage (<xref ref-type="bibr" rid="bib53">Minoux and Rijli, 2010</xref>). To do so, cranial neural crest cells express transcription factors such as Sox9, Sox10, and Twist1 that specify cell fate decisions in derivatives of the neural crest (<xref ref-type="bibr" rid="bib1">Bertol et al., 2022</xref>; <xref ref-type="bibr" rid="bib7">Cheung et al., 2005</xref>). Pre-migratory neural crest cell specification is partially controlled by the epigenetic regulator Polycomb repressive complex 2 (PRC2), an H3K27 histone methyltransferase that is broadly responsible for chromatin compaction and transcriptional silencing (<xref ref-type="bibr" rid="bib49">Margueron and Reinberg, 2011</xref>). The catalytic activity of PRC2 is comprised of four core subunits: (1) enhancer of zeste homologue 1 (Ezh1) or Ezh2, (2) suppressor of zeste 12 (Suz12), (3) RBBP4 or RBBP7, and (4) embryonic ectoderm development (Eed) (<xref ref-type="bibr" rid="bib65">Piunti and Shilatifard, 2021</xref>). Eed binds to H3K27 trimethylation peptides (H3K27me3) and stabilizes Ezh2 for allosteric activation of methyltransferase activity and the on-chromatin spreading of H3K27me3. <italic>Eed</italic> is required for stem cell plasticity, pluripotency, and maintaining cell fate decisions, but all PRC2 core subunits are required for embryonic development, and the loss of any individual subunit is embryonic lethal around gastrulation (<xref ref-type="bibr" rid="bib16">Faust et al., 1995</xref>; <xref ref-type="bibr" rid="bib62">O’Carroll et al., 2001</xref>; <xref ref-type="bibr" rid="bib63">Pasini et al., 2004</xref>). <italic>Eed</italic> null embryos can initiate endoderm and mesoderm induction but have global anterior-posterior patterning defects in the primitive streak (<xref ref-type="bibr" rid="bib16">Faust et al., 1995</xref>; <xref ref-type="bibr" rid="bib69">Schumacher et al., 1996</xref>) and genome-wide defects in H3K27me3 (<xref ref-type="bibr" rid="bib55">Montgomery et al., 2007</xref>).</p><p>Ezh2 has been studied in the context of pre-migratory neural crest development. In mice, <italic>Wnt1-Cre Ezh2<sup>Fl/Fl</sup></italic> embryos fail to develop skull and mandibular structures due to de-repression of Hox transcription factors in cranial neural crest cells (<xref ref-type="bibr" rid="bib17">Ferguson et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Kim et al., 2018</xref>; <xref ref-type="bibr" rid="bib70">Schwarz et al., 2014</xref>), and loss of <italic>Ezh2</italic> in mesenchymal precursor cells causes skeletal defects and craniosynostosis in <italic>Prrx1-Cre Ezh2<sup>Fl/Fl</sup></italic> embryos (<xref ref-type="bibr" rid="bib13">Dudakovic et al., 2015</xref>). Ezh2 also regulates neural crest specification in Xenopus (<xref ref-type="bibr" rid="bib80">Tien et al., 2015</xref>), and <italic>Col2-Cre Eed<sup>Fl/Fl</sup></italic> mice have kyphosis and accelerated hypertrophic differentiation due to de-repression of Wnt and TGF-β signaling in chondrocytes (<xref ref-type="bibr" rid="bib54">Mirzamohammadi et al., 2016</xref>). Genetic and molecular interactions allow <italic>Eed</italic> to repress Hox genes to maintain vertebral body identity during mouse development (<xref ref-type="bibr" rid="bib35">Kim et al., 2006</xref>), but the embryonic, cellular, and molecular consequences of <italic>Eed</italic> activity in craniofacial development remain incompletely understood. To address this gap in our understanding of epigenetic mechanisms that may contribute to craniofacial development, we conditionally deleted <italic>Eed</italic> from the migratory neural crest and its derivatives. Our results suggest that <italic>Eed</italic> is required for craniofacial osteoblast differentiation from post-migratory neural crest, mesenchymal stem cell maintenance, and that <italic>Eed</italic> epigenetically regulates diverse transcription factor programs that are required for mesenchymal cell proliferation, differentiation, and osteogenesis. More broadly, these data show that <italic>Eed</italic> is required at early post-migratory stages in neural crest progenitors of craniofacial structures.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Loss of Eed after neural crest induction causes severe craniofacial malformations</title><p>To determine if <italic>Eed</italic> is required for the development of neural crest derivatives, homozygous floxed <italic>Eed</italic> alleles (<italic>Eed<sup>Fl/Fl</sup></italic>) (<xref ref-type="bibr" rid="bib86">Yu et al., 2009</xref>) were used to conditionally delete <italic>Eed</italic> following neural crest cell induction using Cre recombinase under the control of the <italic>Sox10</italic> promoter, which is expressed in the migratory neural crest at embryonic day (E)8.75 and results in complete recombination in post-migratory neural crest cells by E10.5 (<xref ref-type="bibr" rid="bib50">Matsuoka et al., 2005</xref>; <xref ref-type="bibr" rid="bib61">Niethamer et al., 2020</xref>). <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> mice were not recovered past postnatal day 0, suggesting that loss of <italic>Eed</italic> following induction of the neural crest is embryonic lethal (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). However, <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos were recovered at expected genotypic frequencies from E9.5 to E17.5 (<xref ref-type="fig" rid="fig1">Figure 1a</xref>), and there were no differences in the penetrance or severity of <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> phenotypes whether Cre was maternally or paternally inherited, as has been reported for other phenotypes arising in cells expressing <italic>Sox10-Cre</italic> (<xref ref-type="bibr" rid="bib11">Crispino et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Luo et al., 2020</xref>). No overt phenotypes were identified at early post-migratory neural crest cell stages E10.5 or E11.5, but craniofacial malformations were seen in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos starting at E12.5 that increased in severity throughout the remainder of embryonic development (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> phenotypes were broadly consistent with impaired development of craniofacial structures (<xref ref-type="bibr" rid="bib17">Ferguson et al., 2018</xref>; <xref ref-type="bibr" rid="bib70">Schwarz et al., 2014</xref>), including frontonasal and mandibular hypoplasia, a prominent telencephalon and exencephaly resulting from underdevelopment of the viscerocranium and frontal calvarium, collapsed nasal cavity bones, and microtia compared to controls (<xref ref-type="fig" rid="fig1">Figure 1c</xref>). <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos had increased pupillary distance and craniofacial width (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a–d</xref>), and whole-mount DAPI imaging of <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos revealed severe frontonasal dysplasia with underdeveloped midface and mandible, and an irregular and corrugated facial structure compared to controls (<xref ref-type="fig" rid="fig1">Figure 1d</xref>). Although PRC2 is ubiquitously expressed in the developing embryo (<xref ref-type="bibr" rid="bib62">O’Carroll et al., 2001</xref>), <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos did not have cardiac outflow tract defects or other structural heart malformations that can arise from impaired neural crest differentiation (<xref ref-type="bibr" rid="bib43">Lindsay et al., 2001</xref>; <xref ref-type="bibr" rid="bib42">Lindsay et al., 1999</xref>; <xref ref-type="bibr" rid="bib59">Nakamura et al., 2009</xref>; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2a–d</xref>; <xref ref-type="video" rid="video1">Videos 1</xref> and <xref ref-type="video" rid="video2">2</xref>). Instead, fetal echocardiography showed subtle structural changes but preserved ejection fraction and fractional shortening in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos compared to controls (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2d</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos develop craniofacial malformations.</title><p>(<bold>a</bold>) Genotyping frequencies of postnatal (top) and embryonic (bottom) <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> mice. (<bold>b</bold>) Sagittal bright-field images of <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos from E10.5 to E17.5 showing craniofacial malformations appearing at E12.5 that were observed with 100% penetrance. Scale bar, 1 mm. (<bold>c</bold>) Coronal brightfield images of E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos showing craniofacial malformations. Scale bar, 1 mm. (<bold>d</bold>) Whole-mount fluorescence microscopy of DAPI-stained <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads at E12.5, E14.5, or E16.5. Scale bar, 1 mm. All images are representative of ≥3 biological replicates.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title><italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos develop craniofacial malformations.</title><p>(<bold>a</bold>) Craniofacial measurement quantification of pupillary distance (left) or craniofacial width (right) from E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. (<bold>b</bold>) Body measurement quantification of crown-rump length from E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. Lines represent means and error bars represent standard error of the means. (<bold>c</bold>) Craniofacial measurement quantification of pupillary distance (left) or craniofacial width (right) from E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. (<bold>d</bold>) Body measurement quantification of crown-rump length (left) or body weight (right) from E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. Lines represent means and error bars represent standard error of the means. Student’s t-tests, ***p≤0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title><italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos develop subtle cardiac malformations.</title><p>(<bold>a</bold>) Sagittal view of embryonic day (E)16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (top) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (bottom) embryos in B-mode echocardiography (FL, frontal lobe; NB, nasal bridge; N, nose; UL, upper lip; M, mandible). Scale bar, 1 mm. (<bold>b</bold>) Transversal view of B-mode echocardiography with measurements of left ventricle internal and external areas of an E16.5 embryo. (<bold>c</bold>) M-mode echocardiography of E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (left) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (right) embryos. Four cardiac cycles are included per trace and all cardiac segments are visible in each embryo, as labeled. (<bold>d</bold>) Quantitative echocardiography measurements from <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. Lines represent means and error bars represent standard error of the means. Student’s t-tests, *p≤0.05, **p≤0.01.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig1-figsupp2-v1.tif"/></fig></fig-group><media mimetype="video" mime-subtype="mp4" xlink:href="elife-100159-video1.mp4" id="video1"><label>Video 1.</label><caption><title>B-mode echocardiography movie of an embryonic day (E)16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> heart, transversal view at medium level.</title><p>Both ventricles, external walls, and interventricular septum are visible. Right ventricle is up, and left ventricle is down. The difference in size between ventricles is visible. The ventricular contraction is rhythmic, symmetric, and complete.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-100159-video2.mp4" id="video2"><label>Video 2.</label><caption><title>B-mode echocardiography movie of an embryonic day (E)16.5 <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heart, transversal view at medium level.</title><p>Both ventricles, external walls, and interventricular septum are visible. Right ventricle is up, and left ventricle is down. The ventricular contraction is rhythmic and symmetric.</p></caption></media></sec><sec id="s2-2"><title>Eed regulates craniofacial mesenchymal cell differentiation and proliferation from the early post-migratory neural crest</title><p>Skeletal stains, micro-computed tomography (microCT), histology, and immunofluorescence were used to define how loss of <italic>Eed</italic> impacts craniofacial development. Whole-mount Alcian blue/Alizarin Red staining of <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos revealed hypoplasia of the viscerocranium, including reduced frontal, temporal, maxillary, and mandibular bones, and complete loss of the tympanic ring and premaxillary and nasal bones compared to controls (<xref ref-type="fig" rid="fig2">Figure 2a,b</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a</xref>). MicroCT validated these findings, showing fragmentation and hypoplasia of the frontal, temporal, maxillary, and mandibular bones, loss of frontal calvarial fusion, and absence of tympanic ring and nasal bones (<xref ref-type="fig" rid="fig2">Figure 2c–e</xref> and <xref ref-type="video" rid="video3">Videos 3</xref> and <xref ref-type="video" rid="video4">4</xref>). H&amp;E histology showed that frontal calvarium reduction resulted in anteriorly displaced brain structures in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos compared to controls, with the midbrain and cortex in the same coronal plane as the nasal cavity and developing mandible (<xref ref-type="fig" rid="fig3">Figure 3a</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1b</xref>). Most of the midfacial structures and mandible were absent in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos, and the tongue and masseter muscles were underdeveloped compared to controls (<xref ref-type="fig" rid="fig3">Figure 3a</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Eed is required for craniofacial skeletal development from the neural crest.</title><p>(<bold>a</bold>) Sagittal bright-field images of whole-mount skeletal stains of embryonic day (E)18.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. Alcian blue and Alizarin Red identify cartilage or bone, respectively. Scale bar, 1 mm. (<bold>b</bold>) Magnified sagittal bright-field images of whole-mount skeletal stains of E18.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. Bone structures are annotated (I, interparietal; P, parietal; Mx, maxilla; Mb, mandible; Tr, tympanic ring; F, frontal; N, nasal; T, temporal; S, supraoccipital). Scale bar, 1 mm. (<bold>c</bold>) Micro-computed tomography (microCT) images of E19.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads. Scale bar, 1 mm. (<bold>d</bold>) MicroCT images of E19.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> neural crest-derived craniofacial bones shaded in orange (frontal), gray (maxilla), or green (mandible). Scale bar, 1 mm. (<bold>e</bold>) Magnified microCT images of E19.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> neural crest-derived craniofacial bones. Scale bars, 1 mm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>Sox10-Cre</italic>; <italic>Eed<sup>Fl/Fl</sup></italic> embryos develop significant craniofacial mesenchymal differentiation phenotypes and subtle apoptotic phenotypes.</title><p>(<bold>a</bold>) Coronal bright-field images of whole-mount skeletal stains of embryonic day (E)18.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. Scale bar, 1 mm. (<bold>b</bold>) Bright-field sagittal H&amp;E images of E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads in series from lateral (left) to medial (right). Vibrissa (V) were reduced in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads compared to controls. Scale bar, 1 mm. (<bold>c</bold>) Coronal immunofluorescence images of E15.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads stained for osteocalcin (green). Scale bar, 1 mm. (<bold>d</bold>) Coronal immunofluorescence images of E15.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> mandibles stained for Cleaved Caspase 3 (red). Scale bar, 100 µm. (<bold>e</bold>) Quantification of Cleaved Caspase 3 immunofluorescence labeling index from E15.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> mandibles. Lines represent means and error bars represent standard error of the means. Student’s t-test, **p≤0.01. (<bold>f</bold>) Coronal immunofluorescence images of E15.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads stained for Runx2 (red). Scale bar, 1 mm. All images are representative of ≥3 biological replicates. DNA is marked by DAPI.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig2-figsupp1-v1.tif"/></fig></fig-group><media mimetype="video" mime-subtype="mp4" xlink:href="elife-100159-video3.mp4" id="video3"><label>Video 3.</label><caption><title>Three-dimensional reconstruction of micro-computed tomography (microCT) imaging of an embryonic day (E)19.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> head.</title></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-100159-video4.mp4" id="video4"><label>Video 4.</label><caption><title>Three-dimensional reconstruction of micro-computed tomography (microCT) imaging of an embryonic day (E)19.5 <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> head.</title></caption></media><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Eed regulates craniofacial differentiation and proliferation from the neural crest.</title><p>(<bold>a</bold>) Bright-field coronal H&amp;E images of E15.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads. Anatomic structures are annotated (Ct, cortex; CP, cartilage primordium; CS, conjunctival sac; Gg, genioglossus muscle; HC, hyaloid cavity; Hg, hyoglossus muscle; L, lens; LV, lateral ventricle; Mb, midbrain; MM, masseter muscle; Np, nasopharynx; NC, nasal cavity; OB, olfactory bulb; OE, olfactory epithelium; OM, ocular muscle; RNL, retina neural layer; Sm/St, sublingual and submandibular ducts; T, tongue; TV, third ventricle; VF, vibrissa follicles). Scale bar, 1 mm. (<bold>b</bold>) Coronal immunofluorescence images of E15.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads stained for ALPL (green) and Sox9 (red). Scale bars, 1 mm and 100 µm. (<bold>c</bold>) Coronal immunofluorescence images of E15.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads stained for Ki67 (green) and Vimentin (red). Scale bars, 1 mm and 100 µm. (<bold>d</bold>) Quantification of Ki67 immunofluorescence labeling index from E15.5 heads. (<bold>e</bold>) Coronal immunofluorescence images of E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads stained for Runx2 (red) and Sox9 (green). Intracranial tissues demonstrate ex vacuo dilation and anterior herniation in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads. Scale bars, 500 µm and 100 µm. (<bold>f</bold>) Quantification of immunofluorescence imaging intensity from primary craniofacial cell cultures from E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. All images are representative of ≥3 biological replicates. DNA is marked by DAPI. Lines represent means and error bars represent standard error of the means. Student’s t-tests, **p≤0.01, ***p≤0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Eed regulates craniofacial differentiation and proliferation in vivo and in primary cell cultures.</title><p>(<bold>a</bold>) Coronal immunofluorescence images of embryonic day (E)12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads stained for BrdU (red). Scale bars, 500 µm and 50 µm. (<bold>b</bold>) Quantification of BrdU immunofluorescence labeling index from E12.5 heads. (<bold>c</bold>) Immunofluorescence images of primary craniofacial cell cultures from E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos stained for Eed, Runx2, Ki67, or Sox10. Scale bar, 100 µm. (<bold>d</bold>) Quantification of ALPL immunofluorescence imaging intensity from primary E15.5 craniofacial cell cultures. (<bold>e</bold>) Coronal immunofluorescence images of E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads stained for Sox10 (red). Scale bars, 500 µm and 50 µm. All images are representative of ≥3 biological replicates. DNA is marked by DAPI. Lines represent means and error bars represent standard error of the means. Student’s t-tests, ***p≤0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Immunofluorescence demonstrated disorganized ALPL and Osteocalcin, markers of osteoblasts and mineralizing bone (<xref ref-type="bibr" rid="bib45">Liu et al., 2018</xref>), in craniofacial tissues from <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos compared to controls (<xref ref-type="fig" rid="fig3">Figure 3b</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1c</xref>). Immunofluorescence for Sox9, a marker of chondrocytes that are derived from the neural crest (<xref ref-type="bibr" rid="bib56">Mori-Akiyama et al., 2003</xref>; <xref ref-type="bibr" rid="bib85">Yan et al., 2002</xref>), was also disorganized in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos compared to controls (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). There was a small increase in immunofluorescence labeling index for cleaved Caspase 3 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1d and e</xref>), suggesting that apoptosis may play a subtle role in craniofacial phenotypes from <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos compared to controls. In contrast to <italic>Wnt1-Cre Ezh2<sup>Fl/Fl</sup></italic> embryos (<xref ref-type="bibr" rid="bib17">Ferguson et al., 2018</xref>; <xref ref-type="bibr" rid="bib70">Schwarz et al., 2014</xref>), the craniofacial region of <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos had marked decreased immunofluorescence labeling index for Ki67 (<xref ref-type="fig" rid="fig3">Figure 3c and d</xref>), a marker of cell proliferation (<xref ref-type="bibr" rid="bib20">Gerdes et al., 1984</xref>), and decreased immunofluorescence staining for Vimentin (Vim), a marker of mesenchymal cells (<xref ref-type="bibr" rid="bib51">Mendez et al., 2010</xref>; <xref ref-type="fig" rid="fig3">Figure 3c</xref>). Immunofluorescence for Runx2, a transcription factor that is required for osteoblast differentiation and proliferation (<xref ref-type="bibr" rid="bib33">Kawane et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Komori, 2009</xref>), was also decreased in craniofacial tissues from <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos compared to controls (<xref ref-type="fig" rid="fig3">Figure 3e</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1f</xref>). In support of these findings, (1) BrdU labeling index was decreased in the craniofacial region of <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos compared to controls (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a and b</xref>), (2) immunofluorescence for Eed, Runx2, Ki67, and ALPL was decreased in primary <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> craniofacial cell cultures compared to controls (<xref ref-type="fig" rid="fig3">Figure 3f</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1c</xref>), and (3) there was no change in immunofluorescence for Sox10 in either primary <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> craniofacial cell cultures or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos compared to controls (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1c and e</xref>). These results suggest that craniofacial mesenchymal differentiation, proliferation, and osteogenesis are impaired in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos compared to controls (<xref ref-type="bibr" rid="bib27">Honoré et al., 2003</xref>; <xref ref-type="bibr" rid="bib34">Kim et al., 2003</xref>).</p></sec><sec id="s2-3"><title>Eed regulates craniofacial mesenchymal stem cell, osteoblast, and proliferating mesenchymal cell fate from the early post-migratory neural crest</title><p>To define cell types and gene expression programs underlying craniofacial phenotypes in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos, single-cell RNA sequencing was performed on litter-matched E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> and <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads (n=3 biological replicates per genotype). Uniform manifold approximation and projection (UMAP) analysis of 63,730 single-cell transcriptomes revealed 23 cell clusters (C0-C22) that were defined using automated cell-type classification (<xref ref-type="bibr" rid="bib28">Ianevski et al., 2022</xref>), cell signature genes, cell cycle analysis, and differentially expressed cluster marker genes (<xref ref-type="fig" rid="fig4">Figure 4a</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1</xref>–<xref ref-type="fig" rid="fig4s3">3</xref>, and <xref ref-type="supplementary-material" rid="supp1 supp2">Supplementary file 1 and 2</xref>). Differentiating osteoblasts marked by <italic>Runx2</italic> (C0) and proliferating mesenchymal cells marked by Ki67 (C7) were enriched in <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> samples (<xref ref-type="fig" rid="fig4">Figure 4b–d</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). Mesenchymal stem cells marked by <italic>Col6a3</italic> (C4) or <italic>Dcn</italic> (C5) were enriched in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples (<xref ref-type="fig" rid="fig4">Figure 4b-d</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>), suggesting that loss of <italic>Eed</italic> prevents craniofacial mesenchymal stem cell differentiation (<xref ref-type="bibr" rid="bib30">Jang et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Lamandé et al., 2006</xref>). There were also subtle differences in the number of interneurons (C17, 1.4% vs 1.9% of cells, p=0.01), Schwann cells (C19, 1.0 vs 1.3% of cells, p=0.03), pericytes (C20, 0.7% vs 0.9%, p=0.05), and spinal neurons (C21, 0.5% vs 0.9% of cells, p=0.003) in <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> versus <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples, but each of these comprised a minority of recovered cell types (Student’s t-tests) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). There were no differences between genotypes in the number of chondrocytes (C10, 3.1% vs 2.7%, p=0.09), fibroblasts (C11, 2.6% vs 2.7%, p=0.24), endothelia (C16, 1.9% vs 1.6%, p=0.22), hematopoietic cells, or other recovered cell types (Student’s t-tests) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Eed regulates craniofacial mesenchymal stem cell, osteoblast, and proliferating mesenchymal cell fate from the neural crest.</title><p>(<bold>a</bold>) Integrated uniform manifold approximation and projection (UMAP) of 63,730 transcriptomes from single-cell RNA sequencing of litter-matched embryonic day (E)12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) heads. (<bold>b</bold>) Integrated UMAP overlaying cell cluster distribution from single-cell RNA sequencing. (<bold>c</bold>) Quantification of mesenchymal cell cluster distribution from single-cell RNA sequencing. Lines represent means and error bars represent standard error of the means. Student’s t-tests, **p≤0.01, ***p≤0.0001. (<bold>d</bold>) Gene expression feature plots of mesenchymal lineages from single-cell RNA sequencing. (<bold>e</bold>) Volcano plot showing differentially expressed genes between C0 (osteoblasts) and C4 (mesenchymal stem cells). (<bold>f</bold>) Volcano plot showing differentially expressed genes between C0 and C5 (mesenchymal stem cells). (<bold>g</bold>) Volcano plot showing differentially expressed genes between two clusters of mesenchymal stem cells from single-cell RNA sequencing of litter-matched E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) heads. (<bold>h</bold>) Volcano plot showing differentially expressed genes in differentiating osteoblasts (C0), mesenchymal stem cells (C4, C5), and proliferating mesenchymal cells (C7) from single-cell RNA sequencing of litter-matched E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) versus <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) heads.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Cell clusters from single-cell RNA sequencing of embryonic day (E)12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads.</title><p>(<bold>a</bold>) Heat map of differentially expressed genes across 23 cell clusters.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Cell cluster marker genes from single-cell RNA sequencing of embryonic day (E)12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads.</title><p>(<bold>a</bold>) Gene expression feature plots for differentially expressed genes across 23 cell clusters.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Mesenchymal cell cluster distribution from single-cell RNA sequencing.</title><p>(<bold>a</bold>) Integrated uniform manifold approximation and projection (UMAP) of transcriptomes from single-cell RNA sequencing of litter-matched embryonic day (E)12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) heads with shading of mesenchymal cell clusters C0 (differentiating osteoblasts), C4 (mesenchymal stem cells), C5 (mesenchymal stem cells), and C7 (proliferating mesenchymal stem cells) across genotypes. Differentiating and proliferating mesenchymal cells are enriched in <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> heads, and mesenchymal stem cells are enriched in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig4-figsupp3-v1.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Single-cell transcriptome differential expression analyses among mesenchymal cell clusters.</title><p>(<bold>a</bold>) Gene expression feature plots for differentially expressed genes between C0 (differentiating osteoblasts) and C4 (mesenchymal stem cells). (<bold>b</bold>) Gene expression feature plots for differentially expressed genes between C0 and C5 (mesenchymal stem cells). (<bold>c</bold>) Gene expression feature plots for differentially expressed genes between mesenchymal stem cell clusters C4 and C5.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig4-figsupp4-v1.tif"/></fig></fig-group><p>Differential expression analysis of single-cell transcriptomes from differentiating osteoblasts (C0), which were enriched in <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> samples (<xref ref-type="fig" rid="fig4">Figure 4c</xref>), compared to mesenchymal stem cells marked by <italic>Col6a3</italic> (C4), which were enriched in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples (<xref ref-type="fig" rid="fig4">Figure 4c</xref>), showed <italic>Sox5</italic> and <italic>Sox6</italic> were reduced in mesenchymal stem cells (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>, and <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). These data are consistent with the known role of Sox transcription factors in craniofacial specification and development (<xref ref-type="bibr" rid="bib75">Smits et al., 2001</xref>). Iroquois homeobox (Irx) transcription factors 3 and 5, which contribute to craniofacial osteogenesis and mineralization (<xref ref-type="bibr" rid="bib3">Bonnard et al., 2012</xref>; <xref ref-type="bibr" rid="bib5">Cain et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Tan et al., 2020</xref>), were also suppressed in mesenchymal stem cells compared to differentiating osteoblasts (<xref ref-type="fig" rid="fig4">Figure 4e</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4a</xref>, and <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p><p>Differential expression analysis of single-cell transcriptomes from differentiating osteoblasts compared to mesenchymal stem cells marked by <italic>Dcn</italic> (C5), which were also enriched in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples (<xref ref-type="fig" rid="fig4">Figure 4c</xref>), showed <italic>Mecom</italic>, <italic>Trps1,</italic> and <italic>Ptch1</italic> were suppressed, and <italic>Sparc</italic> and <italic>Tnmd</italic> were enriched in mesenchymal stem cells (<xref ref-type="fig" rid="fig4">Figure 4f</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4b</xref>, and <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Loss of <italic>Mecom</italic> causes craniofacial malformations in mice and zebrafish (<xref ref-type="bibr" rid="bib73">Shull et al., 2020</xref>), <italic>Ptch1</italic> is a key component of the Hedgehog pathway that is crucial for craniofacial osteogenesis (<xref ref-type="bibr" rid="bib31">Jeong et al., 2004</xref>; <xref ref-type="bibr" rid="bib52">Metzis et al., 2013</xref>), and <italic>Trps1</italic> regulates secondary palate and vibrissa development (<xref ref-type="bibr" rid="bib8">Cho et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Fantauzzo and Christiano, 2012</xref>). Consistently, <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples had decreased vibrissa compared to controls (<xref ref-type="fig" rid="fig1">Figure 1d</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1b</xref>). <italic>Sparc</italic> drives morphogenesis of the pharyngeal arches and inner ear (<xref ref-type="bibr" rid="bib67">Rotllant et al., 2008</xref>), and <italic>Tnmd</italic> regulates mesenchymal differentiation (<xref ref-type="bibr" rid="bib72">Shukunami et al., 2006</xref>). <italic>Pax3</italic> and <italic>Pax7,</italic> key regulators of neural crest migration and development of skeletal structures (<xref ref-type="bibr" rid="bib48">Maczkowiak et al., 2010</xref>), were also suppressed in mesenchymal stem cells compared to differentiating osteoblasts (<xref ref-type="fig" rid="fig4">Figure 4f</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4b</xref>, and <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p><p>Differential expression analysis of single-cell transcriptomes from the two clusters of mesenchymal stem cells that were marked by <italic>Col6a3</italic> (C4) versus <italic>Dcn</italic> (C5), both of which were enriched in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples (<xref ref-type="fig" rid="fig4">Figure 4c</xref>), showed <italic>Twist2</italic>, <italic>Irx3</italic>, and <italic>Irx5</italic>, which regulate mesenchymal differentiation to osteoblasts (<xref ref-type="bibr" rid="bib39">Lee et al., 2000</xref>; <xref ref-type="bibr" rid="bib77">Tamamura et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Tan et al., 2020</xref>), distinguished mesenchymal stem cell populations (<xref ref-type="fig" rid="fig4">Figure 4g</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4c</xref>, and <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>).</p><p>To determine if there were differences in the gene expression programs of differentiating osteoblasts (C0), mesenchymal stem cells (C4, C5), or proliferating mesenchymal cells (C7) in <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> versus <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples, differential expression analysis was performed on all single-cell transcriptomes from these clusters between genotypes (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Consistent with craniofacial findings after loss of <italic>Ezh2</italic> (<xref ref-type="bibr" rid="bib17">Ferguson et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Kim et al., 2018</xref>; <xref ref-type="bibr" rid="bib70">Schwarz et al., 2014</xref>) and vertebral body findings after loss of <italic>Eed</italic> (<xref ref-type="bibr" rid="bib35">Kim et al., 2006</xref>), Hox transcription factors were broadly de-repressed in mesenchymal cell populations from <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples compared to controls (<xref ref-type="fig" rid="fig4">Figure 4h</xref>). PRC2 targets Sp7 in bone marrow stroma cells (<xref ref-type="bibr" rid="bib44">Liu et al., 2013</xref>) and regulates Wnt signaling in dental stem cells (<xref ref-type="bibr" rid="bib32">Jing et al., 2016</xref>), and differential expression analysis also showed that <italic>Sp7</italic> was enriched in mesenchymal single-cell transcriptomes from <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> samples and that the Wnt and stem cell regulator gene <italic>Gata4</italic> was enriched in mesenchymal single-cell transcriptomes from <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples (<xref ref-type="fig" rid="fig4">Figure 4h</xref>). <italic>Mki67</italic>, <italic>Pax3</italic>, and <italic>Pax7</italic> were enriched in mesenchymal single-cell transcriptomes from <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> samples, and the cell cycle inhibitors <italic>Cdkn2a</italic> and <italic>Cdkn2b</italic> were enriched in mesenchymal single-cell transcriptomes from <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples (<xref ref-type="fig" rid="fig4">Figure 4h</xref>). In sum, these data show that <italic>Eed</italic> specifies craniofacial osteoblast differentiation and mesenchymal cell proliferation by regulating diverse transcription factor programs required for the specification of post-migratory neural crest cells, and that loss of <italic>Eed</italic> inhibits mesenchymal stem cell differentiation and mesenchymal cell proliferation. These data contrast with the function of <italic>Eed</italic> in chondrocytes, where genetic inactivation of <italic>Eed</italic> at a later stage in mesenchymal development accelerates hypertrophic differentiation, leading to hypoxia and cell death (<xref ref-type="bibr" rid="bib54">Mirzamohammadi et al., 2016</xref>).</p></sec><sec id="s2-4"><title>Eed regulates H3K27me3 deposition at transcription factor loci that are required for craniofacial development</title><p>To determine if genome-wide methylation changes underlie phenotypes and gene expression changes after <italic>Eed</italic> deletion in post-migratory neural crest cells, H3K27me3 CUT&amp;Tag chromatin profiling was performed on nuclei harvested from E12.5 or E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> craniofacial tissues (n=3 biological replicates per genotype per timepoint). At E12.5, conditional <italic>Eed</italic> deletion was associated with global decreases in H3K27me3 deposition and also decreased H3K27me3 deposition at differentially expressed mesenchymal cell cluster genes from single-cell RNA sequencing (C0, C4, C5, C7) (<xref ref-type="fig" rid="fig5">Figure 5a</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Decreased H3K27me3 deposition was observed with conditional <italic>Eed</italic> deletion at E16.5, albeit to a lesser extent (<xref ref-type="fig" rid="fig5">Figure 5b</xref>), likely from relative loss of Sox10+ cells that failed to differentiate or proliferate during development without <italic>Eed</italic> and compensatory colonizing of the craniofacial region by Sox10- Eed+ cells.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>Eed</italic> regulates <italic>H3K27me3</italic> deposition at transcription factor loci that are required for craniofacial development.</title><p>(<bold>a</bold>) Metaplots of H3K27me3 occupancy within 10 kb of all genes or within 10 kb of differentially expressed mesenchymal cell cluster (C0, C4, C5, C7) from CUT&amp;Tag sequencing of embryonic day (E)12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) craniofacial tissues. (<bold>b</bold>) Metaplots of H3K27me3 occupancy within 10 kb of all genes or within 10 kb of differentially expressed mesenchymal cell cluster genes (C0, C4, C5, C7) from CUT&amp;Tag sequencing of E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) craniofacial tissues. (<bold>c</bold>) Distribution of H3K27me3 signal identifying 115 methylation-rich regions (MRRs, shaded) in E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) and 111 MRRs in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) craniofacial tissues. (<bold>d</bold>) Distribution of H3K27me3 signal identifying 147 MRRs in E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) and 123 MRRs in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) craniofacial tissues. (<bold>e</bold>) H3K27me3 tracks at selected loci overlayed from E12.5 or E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3 per timepoint) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3 per timepoint) craniofacial tissues.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Gene ontology analyses of H3K27me3 rich regions from embryonic day (E)12.5 or E16.5 <italic>Sox10-Cre</italic>; <italic>Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre</italic>; <italic>Eed<sup>Fl/Fl</sup></italic> craniofacial tissues.</title><p>(<bold>a</bold>) Gene ontology biological process (2025) terms from E12.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) methylation-rich regions (MRRs). (<bold>b</bold>) Gene ontology biological process (2025) terms from E16.5 <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> (n=3) or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> (n=3) MRRs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100159-fig5-figsupp1-v1.tif"/></fig></fig-group><p>The gene-specific impact of <italic>Eed</italic>-dependent H3K27me3 deposition was assessed by ranking genes from CUT&amp;Tag chromatin profiling based on relative H3K27me3 signal for identification of methylation-rich regions (MRRs). There were 115 MRRs in <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> and 111 MRRs in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> craniofacial tissues at E12.5 (72 overlapping, 31.9%) and 147 MRRs in <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> and 123 MRRs in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> craniofacial tissues at E16.5 (105 overlapping, 38.9%) (<xref ref-type="fig" rid="fig5">Figure 5c and d</xref>, <xref ref-type="supplementary-material" rid="supp7 supp8 supp9 supp10">Supplementary files 7–10</xref>). Ontology analyses of MRRs from <italic>Sox10-Cre; Eed<sup>Fl/WT</sup></italic> or <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> craniofacial tissues showed widespread changes in the H3K27me3 deposition at genes involved in transcriptional regulation and organ development and differentiation (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p><p>Transcription factor loci involved in differentiation and development of craniofacial progenitor cell populations were aberrantly methylated in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> craniofacial tissues compared to controls, including decreased H3K27me3 signal at <italic>Alx1</italic>, <italic>Alx3</italic>, <italic>Barx1</italic>, <italic>Pax7</italic>, and <italic>Tfap2a</italic> loci (<xref ref-type="fig" rid="fig5">Figure 5c and d</xref>, <xref ref-type="supplementary-material" rid="supp7 supp8 supp9 supp10">Supplementary file 7–10</xref>). Mis-regulation of <italic>Alx1</italic> and <italic>Alx3</italic> expression results in craniofacial dysplasia (<xref ref-type="bibr" rid="bib64">Pini et al., 2020</xref>), <italic>Barx1</italic> controls skeletal precursors by promoting cartilage fates (<xref ref-type="bibr" rid="bib60">Nichols et al., 2013</xref>), <italic>Pax7</italic> expression is critical for craniofacial progenitor cell fate (<xref ref-type="bibr" rid="bib58">Murdoch et al., 2012</xref>), and <italic>Tfap2a</italic> influences patterning of the craniofacial skeleton through homeobox gene expression (<xref ref-type="bibr" rid="bib82">Van Otterloo et al., 2022</xref>; <xref ref-type="bibr" rid="bib81">Van Otterloo et al., 2018</xref>). Loci that increased in H3K27me3 signal in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> craniofacial tissues compared to controls resided near genes such as <italic>Twist1</italic> and <italic>Bmp4</italic>, which are required for stabilizing neural crest cell signatures to guide migrating potential (<xref ref-type="bibr" rid="bib14">Fan et al., 2021</xref>; <xref ref-type="bibr" rid="bib23">Goodnough et al., 2016</xref>) and are expressed in the frontal primordium at E12.5 by Msx1 and Msx2 to control craniofacial neural crest cell differentiation (<xref ref-type="bibr" rid="bib25">Han et al., 2007</xref>), respectively.</p><p>To determine if locus-specific H3K27me3 loss translated to increased gene expression, as predicted from functional deletion of PRC2, single-cell RNA sequencing and CUT&amp;Tag data from E12.5 embryos were integrated. Differentially enriched genes in mesenchymal cell clusters (C0, C4, C5, C7) from single-cell RNA sequencing of <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> samples compared to controls included the developmental transcription factors <italic>Vax2</italic> (Ventral Anterior Homeobox 2) and <italic>Foxa1</italic>, <italic>Foxa2</italic>, and <italic>Foxd3</italic> (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>), each of which had gene body or distal element loses in H3K27me3 signal from CUT&amp;Tag chromatin profiling (<xref ref-type="fig" rid="fig5">Figure 5e</xref>). Forkhead box (FOX) transcription factors are required for craniofacial bone and cartilage development, and FOX mis-regulation expands cartilage domains and inhibits bone fate decisions (<xref ref-type="bibr" rid="bib57">Mundell and Labosky, 2011</xref>; <xref ref-type="bibr" rid="bib84">Xu et al., 2018</xref>). These data suggest that Vax2, Foxa1, Foxa2, or Foxd3 may contribute to craniofacial phenotypes observed in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos downstream of H3K27me3 deposition in response to functional deletion of PRC2. More broadly, these data suggest that loss of H3K27me3 signal at developmental gene loci may correlate with gene expression changes that result in aberrant cell fate decisions of craniofacial mesenchymal stem cells, osteoblasts, and proliferating mesenchymal cells from the neural crest.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Epigenetic regulation of the neural crest, which differentiates into diverse mesenchymal derivatives, remains incompletely understood. Here, we identify the PRC2 core subunit <italic>Eed</italic> as a potent regulator of craniofacial development after induction of the neural crest. Conditional deletion of <italic>Eed</italic> using <italic>Sox10-Cre</italic> causes severe craniofacial malformations that are consistent with impaired differentiation and proliferation of cells arising from the pharyngeal arches (<xref ref-type="bibr" rid="bib18">Frisdal and Trainor, 2014</xref>). In support of this hypothesis, we observed severe defects in the development of craniofacial mesenchyme-derived tissues (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig2">2</xref>) that were consistent with molecular and cellular findings from <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos (<xref ref-type="fig" rid="fig3">Figures 3</xref>—<xref ref-type="fig" rid="fig5">5</xref>). Expression of key regulators of craniofacial osteogenesis, such as <italic>Runx2, Irx3</italic>, <italic>Irx5, Mecom, Trps1, Ptch1, Pax3,</italic> and <italic>Pax7</italic>, was reduced in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads and primary craniofacial cell cultures compared to controls, and single-cell RNA sequencing showed reduced craniofacial osteoblast differentiation and reduced proliferation of mesenchymal cells in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> heads compared to controls. H3K27me3 signatures of key developmental transcription factors, including <italic>Barx1</italic>, <italic>Tfap2a</italic>, <italic>Vax2</italic>, <italic>Foxa1</italic>, <italic>Foxa2</italic>, <italic>Foxd3,</italic> and others, were markedly reduced in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> craniofacial tissues compared to controls, suggesting that PRC2 disruption causes widespread mis-regulation of cell fate decision networks in post-migratory neural crest cells. We also identified subtle cardiac phenotypes and a small increase in apoptosis in <italic>Sox10-Cre; Eed<sup>Fl/Fl</sup></italic> embryos. In sum, these data suggest that PRC2 may contribute to the development of diverse neural crest-derived tissues but is particularly important for craniofacial mesenchymal cell differentiation and proliferation.</p><p>By using <italic>Sox10-Cre</italic>, which marks the migratory neural crest (<xref ref-type="bibr" rid="bib50">Matsuoka et al., 2005</xref>), we bypass potential roles of <italic>Eed</italic> in neural crest cell induction to examine its function in neural crest cell development. The requirement of PRC2 for craniofacial development has been studied in the context of <italic>Ezh2</italic> loss using <italic>Wnt1-Cre</italic> (<xref ref-type="bibr" rid="bib17">Ferguson et al., 2018</xref>; <xref ref-type="bibr" rid="bib70">Schwarz et al., 2014</xref>), but to our knowledge, our study is the first report directly linking <italic>Eed</italic> to differentiation of neural crest-derived mesenchymal cells and the first report of single-cell transcriptomic and epigenomic data underlying these phenotypes.</p><p>To date, 15 human missense mutations in <italic>EED</italic> have been reported as pathogenic for Cohen-Gibson syndrome (<xref ref-type="bibr" rid="bib10">Cohen and Gibson, 2016</xref>; <xref ref-type="bibr" rid="bib9">Cohen et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Goel et al., 2024</xref>). Like Weaver syndrome, which arises from missense mutations in <italic>EZH2</italic> (<xref ref-type="bibr" rid="bib21">Gibson et al., 2012</xref>; <xref ref-type="bibr" rid="bib79">Tatton-Brown et al., 2013</xref>), and Imagawa-Matsumoto syndrome, which arises from missense mutations in <italic>SUZ12</italic> (<xref ref-type="bibr" rid="bib29">Imagawa et al., 2018</xref>), Cohen-Gibson syndrome is a rare congenital syndrome that is associated with craniofacial malformations, advanced bone age, intellectual disability, and developmental delay (<xref ref-type="bibr" rid="bib76">Spellicy et al., 2019</xref>). <italic>EED</italic> mutations in individuals with Cohen-Gibson syndrome cluster in WD40 domains 3 through 5 and are predicted to (1) abolish interaction with EZH2, (2) prevent histone methyltransferase activity, and (3) inhibit H3K27me3 peptide binding. In support of these hypotheses, functional investigations have shown that single nucleotide variants in the WD40 domain of <italic>EED</italic> abolish binding to <italic>EZH2</italic> in vitro (<xref ref-type="bibr" rid="bib12">Denisenko et al., 1998</xref>). Mouse models encoding pathogenic <italic>EZH2</italic> missense variants, which are predicted to result in loss of function of the PRC2 complex, phenocopy Weaver syndrome and cause excess osteogenesis and skeletal overgrowth (<xref ref-type="bibr" rid="bib19">Gao et al., 2023</xref>). In this study, we show that loss of <italic>Eed</italic> after neural crest induction causes the opposite phenotype and results in craniofacial hypoplasia due to impairments in osteogenesis, mesenchymal cell proliferation, and mesenchymal stem cell differentiation. The discrepancy of missense variants in <italic>EED</italic> causing gain of craniofacial osteogenic function in humans versus loss of <italic>Eed</italic> causing loss of craniofacial osteogenic function in mice warrants further study, including investigation using alternative Cre drivers to target different developmental stages, the importance of which is exemplified by limitations associated with some widely used Cre transgenes that target the neural crest (<xref ref-type="bibr" rid="bib40">Lewis et al., 2013</xref>).</p><p>Despite these discrepancies, it is notable that many of the phenotypes we observed after loss of <italic>Eed</italic> in the neural crest of mice were similar to previously reported phenotypes after loss of <italic>Ezh2</italic> in the neural crest cell of mice, with the exception of proliferation deficits after loss of <italic>Eed</italic> but not after loss of <italic>Ezh2</italic> (<xref ref-type="bibr" rid="bib17">Ferguson et al., 2018</xref>; <xref ref-type="bibr" rid="bib70">Schwarz et al., 2014</xref>). The temporal and spatial distribution of <italic>Eed</italic> during embryogenesis is well studied, and <italic>Eed</italic> is ubiquitously expressed starting at E5.5, peaks at E9.5, and is downregulated but maintained at a high basal level through E18.5 (<xref ref-type="bibr" rid="bib69">Schumacher et al., 1996</xref>). Although comprehensive analysis of <italic>Eed</italic> expression in neural crest tissues has not been reported (to our knowledge), <italic>Eed</italic> physically and functionally interacts with <italic>Ezh2</italic> (<xref ref-type="bibr" rid="bib71">Sewalt et al., 1998</xref>), which is enriched at a diversity of timepoints throughout all developing craniofacial tissues (<xref ref-type="bibr" rid="bib17">Ferguson et al., 2018</xref>; <xref ref-type="bibr" rid="bib70">Schwarz et al., 2014</xref>). We confirmed enrichment of <italic>Eed</italic> expression in craniofacial tissues throughout development using qPCR, and our single-cell RNA sequencing data failed to reveal any differences in expression of other PRC2 complex members across genotypes. Thus, the available data suggest that there are similarities and that there may be subtle differences in the activity of PRC2 core subunits in developing craniofacial tissues.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p>Mice were maintained in the University of California San Francisco (UCSF) pathogen-free animal facility in accordance with the guidelines established by the Institutional Animal Care and Use Committee (IACUC) and Laboratory Animal Resource Center (LARC) protocol AN191840. Mice were maintained in a 70°F, 50% humidity temperature-controlled barrier facilities under a 12–12 hr light cycle with access to food and water ad libitum. Sox10-Cre and <italic>Eed<sup>Fl</sup></italic> mice were obtained from the Jackson Laboratory (B6;CBA-Tg(Sox10-cre)1Wdr/J, 025807 and B6;129S1-Eed<sup>tm1Sho</sup>/J, 022727, respectively). The presence of the floxed <italic>Eed</italic> allele was determined through standard PCR genotyping using the following primers: 5’ <named-content content-type="sequence">GGGACGTGCTGACATTTTCT</named-content> 3’ (forward) and 5’ <named-content content-type="sequence">CTTGGGTGGTTTGGCTAAGA</named-content> 3’ (reverse). To generate embryos at specific time points, <italic>Sox10-Cretg<sup>tg+</sup> Eed<sup>Fl/WT</sup></italic> mice were bred overnight with <italic>Eed<sup>Fl/Fl</sup></italic> mice. Females were checked for copulation plugs in the morning, and the presence of a vaginal plug was designated as E0.5.</p></sec><sec id="s4-2"><title>Mouse fetal echocardiography</title><p>Ultrasound studies were acquired with a Fujifilm Vevo 2100 Imaging system, and instrument specifically designed for lab animal imaging studies. Pregnant females were anesthetized using an isoflurane/oxygen mixture with an isoflurane concentration of 3% during imaging. The pregnancy date (at least p17) was checked to observe the correct development of fetal hearts. Isoflurane was increased until 5% and the abdomen of pregnant females was open surgically to expose the gravid uterus. The number of fetuses was counted, and craniofacial architecture was evaluated for phenotypic confirmation. Once each fetus was defined as mutant or wild type, echocardiography was performed to evaluate left ventricle anatomy and physiology, including left ventricle size and contractility. Three different measurements were obtained in B and M modes, and functional parameters, including heart rate, fraction shortening, ejection fraction, and left ventricle mass, were obtained.</p></sec><sec id="s4-3"><title>Whole-mount embryo staining</title><p>Embryos were stained as previously described (<xref ref-type="bibr" rid="bib68">Sandell et al., 2018</xref>). In brief, embryos were harvested, and heads were fixed overnight in 4% PFA. Embryos were dehydrated through a methanol series up to 100% before being treated with Dent’s bleach (4:1:1, MeOH, DMSO, 30% H<sub>2</sub>O<sub>2</sub>) for 2 hr at 25°C. Embryos were serially rehydrated in methanol up to 25%, washed with PBST, and stained with DAPI solution (1:40,000, Thermo Scientific, cat# 62248) overnight at 4°C. Samples were mounted in low melt agarose for imaging.</p></sec><sec id="s4-4"><title>Whole-mount skeletal staining</title><p>Embryos were stained as previously described (<xref ref-type="bibr" rid="bib66">Rigueur and Lyons, 2013</xref>). In brief, embryos were dissected in cold PBS and scalded in hot water to facilitate the removal of eyes, skin, and internal organs. Embryos were fixed in 95% ethanol overnight, then subsequently incubated in acetone overnight. Embryos were stained with Alcian blue solution (Newcomer Supply, cat# 1300B) for 8 hr, washed in 70% ethanol, and destained in 95% ethanol. Embryos were cleared in 95% ethanol and 1% KOH and stained in Alizarin Red S solution (SCBT, cat# 130-22-3) for 4 hr. Embryos were stored in glycerol for imaging.</p></sec><sec id="s4-5"><title>Micro-computed tomography</title><p>microCT studies were acquired with a Perkin Elmer’s Quantum GX2 microCT Imaging system, an instrument specifically designed for lab animal imaging studies. The samples were imaged in Eppendorf tubes containing preservative media, which were placed on the scanning bed and fixed with tape to minimize movement. Acquisition parameters were set as follows: FOV 10 mm, acquisition time 14 min, current voltage 70 kV, amperage 114 µA. Each study was composed of a 512×512×512 voxels matrix with a spatial resolution of 0.018 mm<sup>3</sup>. Study reconstruction was based on Feldkamp’s method using instrument dedicated software. For image analysis, tridimensional renders were obtained using 3D SLICER software. The threshold range applied for bone segmentation was 300–1400 Hounsfield units. For the segmentation and visualization of individual frontal bones, cranial base, and mandible, Avizo Lite software (v9.1.1) was used. The threshold range applied was 570–1570 Hounsfield units.</p></sec><sec id="s4-6"><title>Cryosectioning and H&amp;E staining</title><p>Embryos were fixed in 4% PFA overnight at 4°C and subjected to a sucrose gradient from 15% to 30% before embedding in OCT (Tissue-Tek, cat# 4583) and storage at –80°C. Embryos were sectioned at 25 µm on a Leica CM1850 cryostat. Slides were immediately subjected to H&amp;E staining as previously described (<xref ref-type="bibr" rid="bib6">Cardiff et al., 2014</xref>) or stored at –80°C for immunofluorescence.</p></sec><sec id="s4-7"><title>Immunofluorescence</title><p>Immunofluorescence of cryosections was performed on glass slides. Immunofluorescence for primary cells was performed on glass coverslips. Primary cells were fixed in 4% PFA for 10 min at room temperature. Antibody incubations were performed in blocking solution (0.1% Triton X-100, 1% BSA, 10% donkey serum) for 2 hr at room temperature or overnight at 4°C. Slides or coverslips were mounted in ProLong Diamond Antifade Mountant (Thermo Scientific, cat# P36965). Primary antibodies used in this study were anti-Sox9 (1:500, Proteintech, cat# 67439-1-Ig), anti-Sox9 (1:500, Abcam, cat# ab185230), anti-Runx2 (1:500, Cell Signaling, cat# D1L7F), anti-Ki67 (1:2000, Abcam, cat# ab15580), anti-Vimentin (1:1000, Abcam, cat# ab8069), anti-BrdU (1:1000, Abcam, cat# ab6326), anti-Sox10 (1:500, Cell Signaling, cat# D5V9L), anti-ALPL (1:1000, Invitrogen, cat# PA5-47419), anti-Eed (1:1000, Cell Signaling, cat# E4L6E), and anti-Cleaved Caspase-3 (Asp175) (1:500, Cell Signaling, cat#9661). Secondary antibodies used in this study were Donkey anti-Rabbit IgG (H+L) Alexa Fluor Plus 555 (1:1000, Thermo Scientific, cat# A32794), Donkey anti-Rabbit IgG (H+L) Alexa Fluor 488 (1:1000, Thermo Scientific, cat# A21206), and Donkey anti-Rabbit IgG (H+L) Alexa Fluor Plus 568 (1:1000, Thermo Scientific, cat# A10042). DAPI solution (1:5000, Thermo Scientific, cat# 62248) was added to secondary antibody solutions. Slides or coverslips were mounted in ProLong Diamond Antifade Mountant (Thermo Scientific, cat# P36965) and cured overnight before imaging.</p></sec><sec id="s4-8"><title>BrdU staining</title><p>Timed mating dams were subjected to intraperitoneal injection of 100 mg/kg sterile BrdU in PBS (Abcam, cat# ab142567). After 4 hr, mice were euthanized, and embryos were harvested in cold PBS. Embryos were fixed in 4% PFA overnight at 4°C and cryosectioned. Sections were incubated with 1 M HCl for 2 hr then 0.1 M sodium borate buffer for 15 min before being subjected to standard immunofluorescence.</p></sec><sec id="s4-9"><title>Microscopy and image analysis</title><p>Whole-mount skeletal and H&amp;E stains were imaged using a Zeiss Stemi 305 Stereo Zoom microscope running Zeiss Blue v2.0. Whole-mount embryo DAPI stains were imaged using an upright Zeiss Axio Imager Z2 running AxioVision v4.0. Immunofluorescence images were obtained using a Zeiss LSM800 confocal laser scanning microscope running Zen Blue v2.0. Quantification of embryo measurements and immunofluorescence staining intensities was performed in ImageJ using standard thresholding and measurement of signal integrated density. Signal to nuclei normalization was performed by dividing signal intensity by DAPI signal per image. Quantification was performed using n&gt;6 images per embryo. Proliferation index was calculated by dividing the number of Ki67+ or BrdU+ nuclei by the total number of DAPI-stained nuclei per image.</p></sec><sec id="s4-10"><title>Primary craniofacial cell culture</title><p>Timed mating embryos were dissected on ice-cold PBS and heads were removed. Brains and eyes were removed from each head, and the remaining craniofacial structures were minced with a sterile blade on a glass surface. Tissue was enzymatically dissociated in 3 mg/ml Collagenase Type 7 (Worthington, cat# CLS-6) in HBSS for 2–3 hr at 37°C with frequent trituration using an Eppendorf ThermoMixer. Dissociated cells were filtered through a 70 µM MACS smart strainer (Miltenyi Biotec, cat# 130-110-916) and either plated on coverslips or cell culture dishes. Primary craniofacial cells were grown in DMEM with 10% FBS. For RNA extraction and immunofluorescence, cells were harvested 1 day following initial dissociation.</p></sec><sec id="s4-11"><title>Single-cell RNA sequencing</title><p>Matched littermate timed embryos were dissected on ice-cold PBS. Embryo heads were removed and minced using sterile razor blades on a glass surface. Tissue was enzymatically dissociated in 3 mg/ml Collagenase Type 7 (Worthington, cat# CLS-6) in HBSS for 2–3 hr at 37°C with frequent trituration using an Eppendorf ThermoMixer. The quality of the dissociation was frequently monitored by looking at the cell suspension on an automated cell counter. Cells were spun down at 350 rcf, resuspended in MACS BSA stock solution (Miltenyi Biotec, cat# 130-091-376), and serially filtered through 70 µm and 40 µm MACS smart strainers (Miltenyi Biotec, cat# 130-110-916). Dissociation quality checks, cell viability, and counting were performed using an Invitrogen Countess 3 automated cell counter. 10,000 cells were loaded per single-cell RNA sequencing sample. Single-cell RNA sequencing libraries were generated using the Chromium Single Cell 3’ Library &amp; Gel Bead Kit v3.1 on a 10x Genomics Chromium controller using the manufacturer’s recommended default protocol and settings.</p></sec><sec id="s4-12"><title>Single-cell RNA sequencing analysis</title><p>Library demultiplexing, read alignment to the mouse reference genome mm10, and unique molecular identifier (UMI) quantification was performed in Cell Ranger v7.2.0. Cells with greater than 200 unique genes were retained for analysis. Data were normalized and variance-stabilized by SCTransform in Seurat v5.0 (<xref ref-type="bibr" rid="bib26">Hao et al., 2024</xref>). UMAP and cluster analysis were performed using the Seurat function RunUMAP with parameters of mindist = 0.7, res = 0.4, dims = 1:30. Cluster markers were identified using the Seurat function FindAllMarkers with parameters min.pct=0.25, thresh.use=0.25. Differential gene expression analysis was performed using DElegate v1.1.0 (<xref ref-type="bibr" rid="bib24">Hafemeister and Halbritter, 2023</xref>) using the DESeq2 method, with biological replicate animals (n=3 per genotype) as the replicate_column parameter. FeaturePlots were generated using SCPubr v1.1.2 (<xref ref-type="bibr" rid="bib2">Blanco-Carmona, 2022</xref>), and scale bars represent log2 UMIs corrected by SCTransform.</p></sec><sec id="s4-13"><title>CUT&amp;Tag sequencing</title><p>E12.5 or E16.5 timed mating embryos were dissected on ice-cold PBS. Craniofacial tissues were microdissected under a Leica Stereoscope, minced, and weighed such that 30 mg of craniofacial tissue was harvested per embryo. Tissue was then processed, and libraries were generated according to the manufacturer’s instructions using an end-to-end CUT&amp;Tag-IT Assay Kit (Active Motif, cat# 53170). In brief, nuclei were mechanically isolated in a Dounce homogenizer with lysis buffer containing protease inhibitors and filtered through a 40 µm strainer. Nuclei were pelleted, washed, and counted such that each reaction was normalized to 500,000 nuclei per embryo. To enable quantitative normalization across samples, 20,000 <italic>Drosophila melanogaster</italic> spike-in nuclei (Active Motif, cat# 53173) were added prior to bead conjugation. Nuclei were then bound to pre-equilibrated concanavalin A-coated magnetic beads and incubated with a primary antibody against H3K27me3 (Active Motif, cat# 39055) along with a <italic>Drosophila</italic>-specific anti-H2Av spike-in antibody (Active Motif, cat# 61686) overnight at 4°C in antibody binding buffer containing 0.05% digitonin, 2 mM EDTA, and 0.1% BSA. Following washes with digitonin-containing buffer, samples were incubated with species-appropriate secondary antibodies for 1  hr at room temperature and subsequently exposed to a pre-loaded pA-Tn5 transposome complex (1:20 dilution) in Dig-300 Buffer for 1  hr to enable tethering. Tagmentation was initiated by the addition of 10 mM MgCl<sub>2</sub> at 37 °C for 1 hr, after which the reaction was terminated with EDTA, 0.1% SDS, and proteinase K digestion at 55°C for 1 hr. DNA was purified using magnetic bead-based cleanup and amplified with i7 and i5 indexed primers using standard PCR amplification. Libraries were cleaned with SPRI beads and quality-assessed on an Agilent Tape Station. Sequencing was performed on an Illumina NovaSeq X with paired-end reads targeting 25 million reads per sample.</p></sec><sec id="s4-14"><title>CUT&amp;Tag sequencing analysis</title><p>Raw H3K27me3 reads were processed using the nf-core Cut&amp;Run pipeline (v1.0.0) and aligned to the mm10 genome. Signal tracks were generated as bigWig files. Replicate bigWigs were merged, averaged, and CPM-normalized using deepTools bamCompare (v3.5.0) with options --normalizeUsing CPM, <monospace>--</monospace>scaleFactorsMethod None, and <monospace>--</monospace>binSize 50. Peaks were called on merged bigWigs using SEACR (v1.3) in stringent mode with an FDR threshold of 0.001. Signal metaplots were generated using deepTools computeMatrix and plotProfile with <monospace>--</monospace>referencePoint center and flanking windows of ±10 kb. Metaplots were generated for all protein-coding genes and for selected differentially expressed genes (DEGs). DEG regions were defined by identifying DEGs from differential expression analyses and retrieving their transcription start site (TSS) coordinates using biomaRt (Ensembl release 106). TSS regions were expanded by ±10 kb, and BED files were generated by excluding genes located on non-autosomal chromosomes (MT, X, Y). The enhancer ranking and super-enhancer identification strategy was adapted from previously described methods (<xref ref-type="bibr" rid="bib46">Lovén et al., 2013</xref>; <xref ref-type="bibr" rid="bib83">Whyte et al., 2013</xref>). Peaks overlapping TSS were removed using BEDTools intersect (v2.31.1) with the -v option. MRRs were identified using ROSE (<xref ref-type="bibr" rid="bib41">Lin et al., 2020</xref>) with default settings, and putative MRRs ranked by area under the curve (AUC) from bigWig signal. Inflection points in AUC-ranked plots were used to define MRRs. MRRs were annotated to the nearest RefSeq gene using the TxDb.Mmusculus.UCSC.mm-10.knownGene (v3.10.0) and org.Mm.eg.db (v3.18.0) packages in R. Hockey-stick plots were generated by plotting H3K27me3 signal versus rank.</p></sec><sec id="s4-15"><title>Statistics</title><p>All experiments were performed with independent biological replicates and repeated, and statistics were derived from biological replicates. Biological replicates are indicated in each figure panel or figure legend. No statistical methods were used to predetermine sample sizes, but sample sizes in this study are similar or larger to those reported in previous publications. Data distribution was assumed to be normal, but this was not formally tested. Investigators were blinded to conditions during data collection and analysis. Bioinformatic analyses were performed blind to clinical features, outcomes, and molecular characteristics. The samples used in this study were nonrandomized with no intervention, and all samples were interrogated equally. Thus, controlling for covariates among samples was not relevant. No data points were excluded from the analyses.</p></sec><sec id="s4-16"><title>Code availability</title><p>No custom software, tools, or packages were used. The open-source software, tools, and packages used for data analysis in this study are referenced in the methods where applicable and include Cell Ranger v7.2.0, Seurat v5.0, DElegate v1.1.0, SCPubr v1.1.2, nf-core Cut&amp;Run (v1.0.0), deepTools bamCompare (v3.5.0), SEACR (v1.3), BEDTools intersect (v2.31.1), TxDb.Mmusculus.UCSC.mm-10.knownGene (v3.10.0), and org.Mm.eg.db (v3.18.0).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Project administration</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Supervision, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Supervision, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Mice were maintained in the University of California San Francisco (UCSF) pathogen-free animal facility in accordance with the guidelines established by the Institutional Animal Care and Use Committee (IACUC) and Laboratory Animal Resource Center (LARC) protocol AN191840.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Cell count per embryo and per cell cluster from single-cell RNA sequencing.</title></caption><media xlink:href="elife-100159-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Single-cell RNA sequencing cluster marker genes.</title></caption><media xlink:href="elife-100159-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Differential gene expression between C4 and C0 from single-cell RNA sequencing.</title></caption><media xlink:href="elife-100159-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Differential gene expression between C5 and C0 from single-cell RNA sequencing.</title></caption><media xlink:href="elife-100159-supp4-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Differential gene expression between C4 and C5 from single-cell RNA sequencing.</title></caption><media xlink:href="elife-100159-supp5-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Differential gene expression between genotypes in C0, C4, C5, and C7 from single-cell RNA sequencing.</title></caption><media xlink:href="elife-100159-supp6-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Methylation rank and nearest gene coordinates from CUT&amp;Tag H3K27me3 sequencing of E12.5 Sox10-Cre; Eed<sup>Fl/WT</sup> craniofacial tissues.</title></caption><media xlink:href="elife-100159-supp7-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp8"><label>Supplementary file 8.</label><caption><title>Methylation rank and nearest gene coordinates from CUT&amp;Tag H3K27me3 sequencing of E12.5 Sox10-Cre; Eed<sup>Fl/Fl</sup> craniofacial tissues.</title></caption><media xlink:href="elife-100159-supp8-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp9"><label>Supplementary file 9.</label><caption><title>Methylation rank and nearest gene coordinates from CUT&amp;Tag H3K27me3 sequencing of E16.5 Sox10-Cre; Eed<sup>Fl/WT</sup> craniofacial tissues.</title></caption><media xlink:href="elife-100159-supp9-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp10"><label>Supplementary file 10.</label><caption><title>Methylation rank and nearest gene coordinates from CUT&amp;Tag H3K27me3 sequencing of E16.5 Sox10-Cre; Eed<sup>Fl/Fl</sup> craniofacial tissues.</title></caption><media xlink:href="elife-100159-supp10-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-100159-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Single-cell RNA sequencing data and CUT&amp;Tag sequencing data that are reported in this manuscript have been deposited in the NCBI Sequence Read Archive under PRJNA1077750 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1077750">https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1077750</ext-link>) and GSE302601 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&amp;acc=GSE302601">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&amp;acc=GSE302601</ext-link>).</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Tim</surname><given-names>C</given-names></name><name><surname>Arun</surname><given-names>P</given-names></name><name><surname>Angelo</surname><given-names>P</given-names></name><name><surname>David</surname><given-names>R</given-names></name><name><surname>John</surname><given-names>LS</given-names></name><name><surname>Juan</surname><given-names>C</given-names></name><name><surname>Camilla</surname><given-names>T</given-names></name><name><surname>Yoon-Gu</surname><given-names>J</given-names></name><name><surname>Harish</surname><given-names>V</given-names></name><name><surname>Jeffrey</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Eed controls craniofacial osteoblast differentiation and mesenchymal proliferation from the neural crest</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&amp;acc=GSE302601">GSE302601</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><collab>University of California, San Francisco</collab></person-group><year iso-8601-date="2024">2024</year><data-title>Eed controls mesenchymal stem cell differentiation in craniofacial derivatives of the neural crest</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1077750">PRJNA1077750</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertol</surname><given-names>JW</given-names></name><name><surname>Johnston</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name><name><surname>Xie</surname><given-names>VK</given-names></name><name><surname>Hubka</surname><given-names>KM</given-names></name><name><surname>Cruz</surname><given-names>L</given-names></name><name><surname>Nitschke</surname><given-names>L</given-names></name><name><surname>Stetsiv</surname><given-names>M</given-names></name><name><surname>Goering</surname><given-names>JP</given-names></name><name><surname>Nistor</surname><given-names>P</given-names></name><name><surname>Lowell</surname><given-names>S</given-names></name><name><surname>Hoskens</surname><given-names>H</given-names></name><name><surname>Claes</surname><given-names>P</given-names></name><name><surname>Weinberg</surname><given-names>SM</given-names></name><name><surname>Saadi</surname><given-names>I</given-names></name><name><surname>Farach-Carson</surname><given-names>MC</given-names></name><name><surname>Fakhouri</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>TWIST1 interacts with β/δ-catenins during neural tube development and regulates fate transition in cranial neural crest cells</article-title><source>Development</source><volume>149</volume><elocation-id>dev200068</elocation-id><pub-id pub-id-type="doi">10.1242/dev.200068</pub-id><pub-id pub-id-type="pmid">35781329</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Blanco-Carmona</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Generating publication ready visualizations for single cell transcriptomics using SCpubr</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.02.28.482303</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnard</surname><given-names>C</given-names></name><name><surname>Strobl</surname><given-names>AC</given-names></name><name><surname>Shboul</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Merriman</surname><given-names>B</given-names></name><name><surname>Nelson</surname><given-names>SF</given-names></name><name><surname>Ababneh</surname><given-names>OH</given-names></name><name><surname>Uz</surname><given-names>E</given-names></name><name><surname>Güran</surname><given-names>T</given-names></name><name><surname>Kayserili</surname><given-names>H</given-names></name><name><surname>Hamamy</surname><given-names>H</given-names></name><name><surname>Reversade</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mutations in IRX5 impair craniofacial development and germ cell migration via SDF1</article-title><source>Nature Genetics</source><volume>44</volume><fpage>709</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1038/ng.2259</pub-id><pub-id pub-id-type="pmid">22581230</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronner</surname><given-names>ME</given-names></name><name><surname>LeDouarin</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Development and evolution of the neural crest: an overview</article-title><source>Developmental Biology</source><volume>366</volume><fpage>2</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.12.042</pub-id><pub-id pub-id-type="pmid">22230617</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cain</surname><given-names>CJ</given-names></name><name><surname>Gaborit</surname><given-names>N</given-names></name><name><surname>Lwin</surname><given-names>W</given-names></name><name><surname>Barruet</surname><given-names>E</given-names></name><name><surname>Ho</surname><given-names>S</given-names></name><name><surname>Bonnard</surname><given-names>C</given-names></name><name><surname>Hamamy</surname><given-names>H</given-names></name><name><surname>Shboul</surname><given-names>M</given-names></name><name><surname>Reversade</surname><given-names>B</given-names></name><name><surname>Kayserili</surname><given-names>H</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name><name><surname>Hsiao</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Loss of Iroquois homeobox transcription factors 3 and 5 in osteoblasts disrupts cranial mineralization</article-title><source>Bone Reports</source><volume>5</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.bonr.2016.02.005</pub-id><pub-id pub-id-type="pmid">27453922</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardiff</surname><given-names>RD</given-names></name><name><surname>Miller</surname><given-names>CH</given-names></name><name><surname>Munn</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Manual hematoxylin and eosin staining of mouse tissue sections</article-title><source>Cold Spring Harbor Protocols</source><volume>2014</volume><fpage>655</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1101/pdb.prot073411</pub-id><pub-id pub-id-type="pmid">24890205</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>M</given-names></name><name><surname>Chaboissier</surname><given-names>MC</given-names></name><name><surname>Mynett</surname><given-names>A</given-names></name><name><surname>Hirst</surname><given-names>E</given-names></name><name><surname>Schedl</surname><given-names>A</given-names></name><name><surname>Briscoe</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The transcriptional control of trunk neural crest induction, survival, and delamination</article-title><source>Developmental Cell</source><volume>8</volume><fpage>179</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2004.12.010</pub-id><pub-id pub-id-type="pmid">15691760</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>KY</given-names></name><name><surname>Kelley</surname><given-names>BP</given-names></name><name><surname>Monier</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Szabo-Rogers</surname><given-names>H</given-names></name><name><surname>Napierala</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Trps1 regulates development of craniofacial skeleton and is required for the initiation of palatal shelves fusion</article-title><source>Frontiers in Physiology</source><volume>10</volume><elocation-id>513</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2019.00513</pub-id><pub-id pub-id-type="pmid">31130868</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>ASA</given-names></name><name><surname>Tuysuz</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Bhalla</surname><given-names>SK</given-names></name><name><surname>Jones</surname><given-names>SJM</given-names></name><name><surname>Gibson</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A novel mutation in EED associated with overgrowth</article-title><source>Journal of Human Genetics</source><volume>60</volume><fpage>339</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/jhg.2015.26</pub-id><pub-id pub-id-type="pmid">25787343</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>AS</given-names></name><name><surname>Gibson</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>EED-associated overgrowth in a second male patient</article-title><source>Journal of Human Genetics</source><volume>61</volume><fpage>831</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1038/jhg.2016.51</pub-id><pub-id pub-id-type="pmid">27193220</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crispino</surname><given-names>G</given-names></name><name><surname>Di Pasquale</surname><given-names>G</given-names></name><name><surname>Scimemi</surname><given-names>P</given-names></name><name><surname>Rodriguez</surname><given-names>L</given-names></name><name><surname>Galindo Ramirez</surname><given-names>F</given-names></name><name><surname>De Siati</surname><given-names>RD</given-names></name><name><surname>Santarelli</surname><given-names>RM</given-names></name><name><surname>Arslan</surname><given-names>E</given-names></name><name><surname>Bortolozzi</surname><given-names>M</given-names></name><name><surname>Chiorini</surname><given-names>JA</given-names></name><name><surname>Mammano</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>BAAV mediated GJB2 gene transfer restores gap junction coupling in cochlear organotypic cultures from deaf Cx26Sox10Cre mice</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e23279</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0023279</pub-id><pub-id pub-id-type="pmid">21876744</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denisenko</surname><given-names>O</given-names></name><name><surname>Shnyreva</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Bomsztyk</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Point mutations in the WD40 domain of Eed block its interaction with Ezh2</article-title><source>Molecular and Cellular Biology</source><volume>18</volume><fpage>5634</fpage><lpage>5642</lpage><pub-id pub-id-type="doi">10.1128/MCB.18.10.5634</pub-id><pub-id pub-id-type="pmid">9742080</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudakovic</surname><given-names>A</given-names></name><name><surname>Camilleri</surname><given-names>ET</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Riester</surname><given-names>SM</given-names></name><name><surname>McGee-Lawrence</surname><given-names>ME</given-names></name><name><surname>Bradley</surname><given-names>EW</given-names></name><name><surname>Paradise</surname><given-names>CR</given-names></name><name><surname>Lewallen</surname><given-names>EA</given-names></name><name><surname>Thaler</surname><given-names>R</given-names></name><name><surname>Deyle</surname><given-names>DR</given-names></name><name><surname>Larson</surname><given-names>AN</given-names></name><name><surname>Lewallen</surname><given-names>DG</given-names></name><name><surname>Dietz</surname><given-names>AB</given-names></name><name><surname>Stein</surname><given-names>GS</given-names></name><name><surname>Montecino</surname><given-names>MA</given-names></name><name><surname>Westendorf</surname><given-names>JJ</given-names></name><name><surname>van Wijnen</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epigenetic control of skeletal development by the histone methyltransferase Ezh2</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>27604</fpage><lpage>27617</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.672345</pub-id><pub-id pub-id-type="pmid">26424790</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Masamsetti</surname><given-names>VP</given-names></name><name><surname>Sun</surname><given-names>JQ</given-names></name><name><surname>Engholm-Keller</surname><given-names>K</given-names></name><name><surname>Osteil</surname><given-names>P</given-names></name><name><surname>Studdert</surname><given-names>J</given-names></name><name><surname>Graham</surname><given-names>ME</given-names></name><name><surname>Fossat</surname><given-names>N</given-names></name><name><surname>Tam</surname><given-names>PP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation</article-title><source>eLife</source><volume>10</volume><elocation-id>e62873</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.62873</pub-id><pub-id pub-id-type="pmid">33554859</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fantauzzo</surname><given-names>KA</given-names></name><name><surname>Christiano</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Trps1 activates a network of secreted Wnt inhibitors and transcription factors crucial to vibrissa follicle morphogenesis</article-title><source>Development</source><volume>139</volume><fpage>203</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1242/dev.069971</pub-id><pub-id pub-id-type="pmid">22115758</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faust</surname><given-names>C</given-names></name><name><surname>Schumacher</surname><given-names>A</given-names></name><name><surname>Holdener</surname><given-names>B</given-names></name><name><surname>Magnuson</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>The eed mutation disrupts anterior mesoderm production in mice</article-title><source>Development</source><volume>121</volume><fpage>273</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1242/dev.121.2.273</pub-id><pub-id pub-id-type="pmid">7768172</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>JW</given-names></name><name><surname>Devarajan</surname><given-names>M</given-names></name><name><surname>Atit</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Stage-specific roles of Ezh2 and Retinoic acid signaling ensure calvarial bone lineage commitment</article-title><source>Developmental Biology</source><volume>443</volume><fpage>173</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2018.09.014</pub-id><pub-id pub-id-type="pmid">30222957</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frisdal</surname><given-names>A</given-names></name><name><surname>Trainor</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Development and evolution of the pharyngeal apparatus</article-title><source>Wiley Interdisciplinary Reviews. Developmental Biology</source><volume>3</volume><fpage>403</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1002/wdev.147</pub-id><pub-id pub-id-type="pmid">25176500</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>CW</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Riddle</surname><given-names>RC</given-names></name><name><surname>Kushwaha</surname><given-names>P</given-names></name><name><surname>Boukas</surname><given-names>L</given-names></name><name><surname>Björnsson</surname><given-names>HT</given-names></name><name><surname>Hansen</surname><given-names>KD</given-names></name><name><surname>Fahrner</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Novel mouse model of Weaver syndrome displays overgrowth and excess osteogenesis reversible with KDM6A/6B inhibition</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.06.23.546270</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdes</surname><given-names>J</given-names></name><name><surname>Lemke</surname><given-names>H</given-names></name><name><surname>Baisch</surname><given-names>H</given-names></name><name><surname>Wacker</surname><given-names>HH</given-names></name><name><surname>Schwab</surname><given-names>U</given-names></name><name><surname>Stein</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67</article-title><source>Journal of Immunology</source><volume>133</volume><fpage>1710</fpage><lpage>1715</lpage><pub-id pub-id-type="pmid">6206131</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>WT</given-names></name><name><surname>Hood</surname><given-names>RL</given-names></name><name><surname>Zhan</surname><given-names>SH</given-names></name><name><surname>Bulman</surname><given-names>DE</given-names></name><name><surname>Fejes</surname><given-names>AP</given-names></name><name><surname>Moore</surname><given-names>R</given-names></name><name><surname>Mungall</surname><given-names>AJ</given-names></name><name><surname>Eydoux</surname><given-names>P</given-names></name><name><surname>Babul-Hirji</surname><given-names>R</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Marra</surname><given-names>MA</given-names></name><collab>FORGE Canada Consortium</collab><name><surname>Chitayat</surname><given-names>D</given-names></name><name><surname>Boycott</surname><given-names>KM</given-names></name><name><surname>Weaver</surname><given-names>DD</given-names></name><name><surname>Jones</surname><given-names>SJM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mutations in EZH2 cause weaver syndrome</article-title><source>American Journal of Human Genetics</source><volume>90</volume><fpage>110</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.11.018</pub-id><pub-id pub-id-type="pmid">22177091</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goel</surname><given-names>H</given-names></name><name><surname>O’Donnell</surname><given-names>S</given-names></name><name><surname>Edwards</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>EED related overgrowth: First report of multiple members in a single family</article-title><source>American Journal of Medical Genetics. Part A</source><volume>194</volume><fpage>374</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.63438</pub-id><pub-id pub-id-type="pmid">37840385</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodnough</surname><given-names>LH</given-names></name><name><surname>Dinuoscio</surname><given-names>GJ</given-names></name><name><surname>Atit</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Twist1 contributes to cranial bone initiation and dermal condensation by maintaining Wnt signaling responsiveness</article-title><source>Developmental Dynamics</source><volume>245</volume><fpage>144</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1002/dvdy.24367</pub-id><pub-id pub-id-type="pmid">26677825</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Halbritter</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Single-cell RNA-seq differential expression tests within a sample should use pseudo-bulk data of pseudo-replicates</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.03.28.534443</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Ishii</surname><given-names>M</given-names></name><name><surname>Bringas</surname><given-names>P</given-names></name><name><surname>Maas</surname><given-names>RL</given-names></name><name><surname>Maxson</surname><given-names>RE</given-names></name><name><surname>Chai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Concerted action of Msx1 and Msx2 in regulating cranial neural crest cell differentiation during frontal bone development</article-title><source>Mechanisms of Development</source><volume>124</volume><fpage>729</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2007.06.006</pub-id><pub-id pub-id-type="pmid">17693062</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Kowalski</surname><given-names>MH</given-names></name><name><surname>Choudhary</surname><given-names>S</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hartman</surname><given-names>A</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Molla</surname><given-names>G</given-names></name><name><surname>Madad</surname><given-names>S</given-names></name><name><surname>Fernandez-Granda</surname><given-names>C</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Dictionary learning for integrative, multimodal and scalable single-cell analysis</article-title><source>Nature Biotechnology</source><volume>42</volume><fpage>293</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/s41587-023-01767-y</pub-id><pub-id pub-id-type="pmid">37231261</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honoré</surname><given-names>SM</given-names></name><name><surname>Aybar</surname><given-names>MJ</given-names></name><name><surname>Mayor</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Sox10 is required for the early development of the prospective neural crest in Xenopus embryos</article-title><source>Developmental Biology</source><volume>260</volume><fpage>79</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/s0012-1606(03)00247-1</pub-id><pub-id pub-id-type="pmid">12885557</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ianevski</surname><given-names>A</given-names></name><name><surname>Giri</surname><given-names>AK</given-names></name><name><surname>Aittokallio</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>1246</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-28803-w</pub-id><pub-id pub-id-type="pmid">35273156</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imagawa</surname><given-names>E</given-names></name><name><surname>Albuquerque</surname><given-names>EVA</given-names></name><name><surname>Isidor</surname><given-names>B</given-names></name><name><surname>Mitsuhashi</surname><given-names>S</given-names></name><name><surname>Mizuguchi</surname><given-names>T</given-names></name><name><surname>Miyatake</surname><given-names>S</given-names></name><name><surname>Takata</surname><given-names>A</given-names></name><name><surname>Miyake</surname><given-names>N</given-names></name><name><surname>Boguszewski</surname><given-names>MCS</given-names></name><name><surname>Boguszewski</surname><given-names>CL</given-names></name><name><surname>Lerario</surname><given-names>AM</given-names></name><name><surname>Funari</surname><given-names>MA</given-names></name><name><surname>Jorge</surname><given-names>AAL</given-names></name><name><surname>Matsumoto</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Novel SUZ12 mutations in weaver‐like syndrome</article-title><source>Clinical Genetics</source><volume>94</volume><fpage>461</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1111/cge.13415</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>YO</given-names></name><name><surname>Cho</surname><given-names>MY</given-names></name><name><surname>Yun</surname><given-names>CO</given-names></name><name><surname>Baik</surname><given-names>SK</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Cha</surname><given-names>SK</given-names></name><name><surname>Chang</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>MY</given-names></name><name><surname>Lim</surname><given-names>YL</given-names></name><name><surname>Kwon</surname><given-names>SO</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Effect of function-enhanced mesenchymal stem cells infected with decorin-expressing adenovirus on hepatic fibrosis</article-title><source>Stem Cells Translational Medicine</source><volume>5</volume><fpage>1247</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.5966/sctm.2015-0323</pub-id><pub-id pub-id-type="pmid">27365486</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>J</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Tenzen</surname><given-names>T</given-names></name><name><surname>Kottmann</surname><given-names>AH</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia</article-title><source>Genes &amp; Development</source><volume>18</volume><fpage>937</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1101/gad.1190304</pub-id><pub-id pub-id-type="pmid">15107405</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>H</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Shuai</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Suppression of EZH2 prevents the shift of osteoporotic msc fate to adipocyte and enhances bone formation during osteoporosis</article-title><source>Molecular Therapy</source><volume>24</volume><fpage>217</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1038/mt.2015.152</pub-id><pub-id pub-id-type="pmid">26307668</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawane</surname><given-names>T</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Komori</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>CA</given-names></name><name><surname>Matsuura-Kawata</surname><given-names>VKDS</given-names></name><name><surname>Sakane</surname><given-names>C</given-names></name><name><surname>Matsuo</surname><given-names>Y</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name><name><surname>Maeno</surname><given-names>T</given-names></name><name><surname>Date</surname><given-names>Y</given-names></name><name><surname>Nishimura</surname><given-names>R</given-names></name><name><surname>Komori</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Runx2 is required for the proliferation of osteoblast progenitors and induces proliferation by regulating Fgfr2 and Fgfr3</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>13551</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-31853-0</pub-id><pub-id pub-id-type="pmid">30202094</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lo</surname><given-names>L</given-names></name><name><surname>Dormand</surname><given-names>E</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells</article-title><source>Neuron</source><volume>38</volume><fpage>17</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(03)00163-6</pub-id><pub-id pub-id-type="pmid">12691661</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Paylor</surname><given-names>SW</given-names></name><name><surname>Magnuson</surname><given-names>T</given-names></name><name><surname>Schumacher</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Juxtaposed Polycomb complexes co-regulate vertebral identity</article-title><source>Development</source><volume>133</volume><fpage>4957</fpage><lpage>4968</lpage><pub-id pub-id-type="doi">10.1242/dev.02677</pub-id><pub-id pub-id-type="pmid">17107999</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Langohr</surname><given-names>IM</given-names></name><name><surname>Faisal</surname><given-names>M</given-names></name><name><surname>McNulty</surname><given-names>M</given-names></name><name><surname>Thorn</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ablation of Ezh2 in neural crest cells leads to aberrant enteric nervous system development in mice</article-title><source>PLOS ONE</source><volume>13</volume><elocation-id>e0203391</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0203391</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komori</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Osteoimmunology, interactions of the immune and skeletal systems II</article-title><source>Advances in Experimental Medicine and Biology</source><volume>658</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1007/978-1-4419-1050-9_5</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamandé</surname><given-names>SR</given-names></name><name><surname>Mörgelin</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>NE</given-names></name><name><surname>Selan</surname><given-names>C</given-names></name><name><surname>Allen</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The C5 domain of the collagen VI α3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>16607</fpage><lpage>16614</lpage><pub-id pub-id-type="doi">10.1074/jbc.M510192200</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Lowe</surname><given-names>G</given-names></name><name><surname>Flanagan</surname><given-names>S</given-names></name><name><surname>Kuchler</surname><given-names>K</given-names></name><name><surname>Glackin</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Human Dermo-1 has attributes similar to twist in early bone development</article-title><source>Bone</source><volume>27</volume><fpage>591</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/s8756-3282(00)00380-x</pub-id><pub-id pub-id-type="pmid">11062344</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>AE</given-names></name><name><surname>Vasudevan</surname><given-names>HN</given-names></name><name><surname>O’Neill</surname><given-names>AK</given-names></name><name><surname>Soriano</surname><given-names>P</given-names></name><name><surname>Bush</surname><given-names>JO</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The widely used Wnt1-Cre transgene causes developmental phenotypes by ectopic activation of Wnt signaling</article-title><source>Developmental Biology</source><volume>379</volume><fpage>229</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2013.04.026</pub-id><pub-id pub-id-type="pmid">23648512</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Orlando</surname><given-names>DA</given-names></name><name><surname>Abraham</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>ROSE</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/younglab/ROSE">https://github.com/younglab/ROSE</ext-link></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>EA</given-names></name><name><surname>Botta</surname><given-names>A</given-names></name><name><surname>Jurecic</surname><given-names>V</given-names></name><name><surname>Carattini-Rivera</surname><given-names>S</given-names></name><name><surname>Cheah</surname><given-names>YC</given-names></name><name><surname>Rosenblatt</surname><given-names>HM</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><name><surname>Baldini</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Congenital heart disease in mice deficient for the DiGeorge syndrome region</article-title><source>Nature</source><volume>401</volume><fpage>379</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1038/43900</pub-id><pub-id pub-id-type="pmid">10517636</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>EA</given-names></name><name><surname>Vitelli</surname><given-names>F</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Morishima</surname><given-names>M</given-names></name><name><surname>Huynh</surname><given-names>T</given-names></name><name><surname>Pramparo</surname><given-names>T</given-names></name><name><surname>Jurecic</surname><given-names>V</given-names></name><name><surname>Ogunrinu</surname><given-names>G</given-names></name><name><surname>Sutherland</surname><given-names>HF</given-names></name><name><surname>Scambler</surname><given-names>PJ</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><name><surname>Baldini</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice</article-title><source>Nature</source><volume>410</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1038/35065105</pub-id><pub-id pub-id-type="pmid">11242049</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Strecker</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Kronenberg</surname><given-names>MS</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Rowe</surname><given-names>DW</given-names></name><name><surname>Maye</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e71318</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0071318</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Xuan</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title><italic>Alpl</italic> prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells</article-title><source>Bone Research</source><volume>6</volume><elocation-id>27</elocation-id><pub-id pub-id-type="doi">10.1038/s41413-018-0029-4</pub-id><pub-id pub-id-type="pmid">30210899</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovén</surname><given-names>J</given-names></name><name><surname>Hoke</surname><given-names>HA</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Lau</surname><given-names>A</given-names></name><name><surname>Orlando</surname><given-names>DA</given-names></name><name><surname>Vakoc</surname><given-names>CR</given-names></name><name><surname>Bradner</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>TI</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Selective inhibition of tumor oncogenes by disruption of super-enhancers</article-title><source>Cell</source><volume>153</volume><fpage>320</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.03.036</pub-id><pub-id pub-id-type="pmid">23582323</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Ambrozkiewicz</surname><given-names>MC</given-names></name><name><surname>Benseler</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Dumontier</surname><given-names>E</given-names></name><name><surname>Falkner</surname><given-names>S</given-names></name><name><surname>Furlanis</surname><given-names>E</given-names></name><name><surname>Gomez</surname><given-names>AM</given-names></name><name><surname>Hoshina</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>WH</given-names></name><name><surname>Hutchison</surname><given-names>MA</given-names></name><name><surname>Itoh-Maruoka</surname><given-names>Y</given-names></name><name><surname>Lavery</surname><given-names>LA</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Maruo</surname><given-names>T</given-names></name><name><surname>Motohashi</surname><given-names>J</given-names></name><name><surname>Pai</surname><given-names>ELL</given-names></name><name><surname>Pelkey</surname><given-names>KA</given-names></name><name><surname>Pereira</surname><given-names>A</given-names></name><name><surname>Philips</surname><given-names>T</given-names></name><name><surname>Sinclair</surname><given-names>JL</given-names></name><name><surname>Stogsdill</surname><given-names>JA</given-names></name><name><surname>Traunmüller</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wortel</surname><given-names>J</given-names></name><name><surname>You</surname><given-names>W</given-names></name><name><surname>Abumaria</surname><given-names>N</given-names></name><name><surname>Beier</surname><given-names>KT</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Burgess</surname><given-names>HA</given-names></name><name><surname>Cepko</surname><given-names>CL</given-names></name><name><surname>Cloutier</surname><given-names>JF</given-names></name><name><surname>Eroglu</surname><given-names>C</given-names></name><name><surname>Goebbels</surname><given-names>S</given-names></name><name><surname>Kaeser</surname><given-names>PS</given-names></name><name><surname>Kay</surname><given-names>JN</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Mandai</surname><given-names>K</given-names></name><name><surname>McBain</surname><given-names>CJ</given-names></name><name><surname>Nave</surname><given-names>KA</given-names></name><name><surname>Prado</surname><given-names>MAM</given-names></name><name><surname>Prado</surname><given-names>VF</given-names></name><name><surname>Rothstein</surname><given-names>J</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name><name><surname>Saher</surname><given-names>G</given-names></name><name><surname>Sakimura</surname><given-names>K</given-names></name><name><surname>Sanes</surname><given-names>JR</given-names></name><name><surname>Scheiffele</surname><given-names>P</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Umemori</surname><given-names>H</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Yuzaki</surname><given-names>M</given-names></name><name><surname>Zoghbi</surname><given-names>HY</given-names></name><name><surname>Kawabe</surname><given-names>H</given-names></name><name><surname>Craig</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Optimizing nervous system-specific gene targeting with cre driver lines: prevalence of germline recombination and influencing factors</article-title><source>Neuron</source><volume>106</volume><fpage>37</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.01.008</pub-id><pub-id pub-id-type="pmid">32027825</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maczkowiak</surname><given-names>F</given-names></name><name><surname>Matéos</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Roche</surname><given-names>D</given-names></name><name><surname>Harland</surname><given-names>R</given-names></name><name><surname>Monsoro-Burq</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The Pax3 and Pax7 paralogs cooperate in neural and neural crest patterning using distinct molecular mechanisms, in <italic>Xenopus laevis</italic> embryos</article-title><source>Developmental Biology</source><volume>340</volume><fpage>381</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2010.01.022</pub-id><pub-id pub-id-type="pmid">20116373</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margueron</surname><given-names>R</given-names></name><name><surname>Reinberg</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The Polycomb complex PRC2 and its mark in life</article-title><source>Nature</source><volume>469</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1038/nature09784</pub-id><pub-id pub-id-type="pmid">21248841</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>T</given-names></name><name><surname>Ahlberg</surname><given-names>PE</given-names></name><name><surname>Kessaris</surname><given-names>N</given-names></name><name><surname>Iannarelli</surname><given-names>P</given-names></name><name><surname>Dennehy</surname><given-names>U</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name><name><surname>Koentges</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Neural crest origins of the neck and shoulder</article-title><source>Nature</source><volume>436</volume><fpage>347</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1038/nature03837</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendez</surname><given-names>MG</given-names></name><name><surname>Kojima</surname><given-names>S-I</given-names></name><name><surname>Goldman</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition</article-title><source>FASEB Journal</source><volume>24</volume><fpage>1838</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1096/fj.09-151639</pub-id><pub-id pub-id-type="pmid">20097873</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzis</surname><given-names>V</given-names></name><name><surname>Courtney</surname><given-names>AD</given-names></name><name><surname>Kerr</surname><given-names>MC</given-names></name><name><surname>Ferguson</surname><given-names>C</given-names></name><name><surname>Rondón Galeano</surname><given-names>MC</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Wainwright</surname><given-names>BJ</given-names></name><name><surname>Wicking</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Patched1 is required in neural crest cells for the prevention of orofacial clefts</article-title><source>Human Molecular Genetics</source><volume>22</volume><fpage>5026</fpage><lpage>5035</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddt353</pub-id><pub-id pub-id-type="pmid">23900075</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minoux</surname><given-names>M</given-names></name><name><surname>Rijli</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Molecular mechanisms of cranial neural crest cell migration and patterning in craniofacial development</article-title><source>Development</source><volume>137</volume><fpage>2605</fpage><lpage>2621</lpage><pub-id pub-id-type="doi">10.1242/dev.040048</pub-id><pub-id pub-id-type="pmid">20663816</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzamohammadi</surname><given-names>F</given-names></name><name><surname>Papaioannou</surname><given-names>G</given-names></name><name><surname>Inloes</surname><given-names>JB</given-names></name><name><surname>Rankin</surname><given-names>EB</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Schipani</surname><given-names>E</given-names></name><name><surname>Orkin</surname><given-names>SH</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Polycomb repressive complex 2 regulates skeletal growth by suppressing Wnt and TGF-β signalling</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12047</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12047</pub-id><pub-id pub-id-type="pmid">27329220</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>ND</given-names></name><name><surname>Yee</surname><given-names>D</given-names></name><name><surname>Montgomery</surname><given-names>SA</given-names></name><name><surname>Magnuson</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation</article-title><source>Journal of Molecular Biology</source><volume>374</volume><fpage>1145</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2007.10.040</pub-id><pub-id pub-id-type="pmid">17997413</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori-Akiyama</surname><given-names>Y</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name><name><surname>de Crombrugghe</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest</article-title><source>PNAS</source><volume>100</volume><fpage>9360</fpage><lpage>9365</lpage><pub-id pub-id-type="doi">10.1073/pnas.1631288100</pub-id><pub-id pub-id-type="pmid">12878728</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mundell</surname><given-names>NA</given-names></name><name><surname>Labosky</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates</article-title><source>Development</source><volume>138</volume><fpage>641</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1242/dev.054718</pub-id><pub-id pub-id-type="pmid">21228004</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murdoch</surname><given-names>B</given-names></name><name><surname>DelConte</surname><given-names>C</given-names></name><name><surname>García-Castro</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Pax7 lineage contributions to the mammalian neural crest</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e41089</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0041089</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Gulick</surname><given-names>J</given-names></name><name><surname>Colbert</surname><given-names>MC</given-names></name><name><surname>Robbins</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Protein tyrosine phosphatase activity in the neural crest is essential for normal heart and skull development</article-title><source>PNAS</source><volume>106</volume><fpage>11270</fpage><lpage>11275</lpage><pub-id pub-id-type="doi">10.1073/pnas.0902230106</pub-id><pub-id pub-id-type="pmid">19541608</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>JT</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Moens</surname><given-names>CB</given-names></name><name><surname>Kimmel</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>barx1 represses joints and promotes cartilage in the craniofacial skeleton</article-title><source>Development</source><volume>140</volume><fpage>2765</fpage><lpage>2775</lpage><pub-id pub-id-type="doi">10.1242/dev.090639</pub-id><pub-id pub-id-type="pmid">23698351</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niethamer</surname><given-names>TK</given-names></name><name><surname>Teng</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>M</given-names></name><name><surname>Du</surname><given-names>YX</given-names></name><name><surname>Percival</surname><given-names>CJ</given-names></name><name><surname>Bush</surname><given-names>JO</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Aberrant cell segregation in the craniofacial primordium and the emergence of facial dysmorphology in craniofrontonasal syndrome</article-title><source>PLOS Genetics</source><volume>16</volume><elocation-id>e1008300</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008300</pub-id><pub-id pub-id-type="pmid">32092051</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Carroll</surname><given-names>D</given-names></name><name><surname>Erhardt</surname><given-names>S</given-names></name><name><surname>Pagani</surname><given-names>M</given-names></name><name><surname>Barton</surname><given-names>SC</given-names></name><name><surname>Surani</surname><given-names>MA</given-names></name><name><surname>Jenuwein</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The polycomb-group gene Ezh2 is required for early mouse development</article-title><source>Molecular and Cellular Biology</source><volume>21</volume><fpage>4330</fpage><lpage>4336</lpage><pub-id pub-id-type="doi">10.1128/MCB.21.13.4330-4336.2001</pub-id><pub-id pub-id-type="pmid">11390661</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasini</surname><given-names>D</given-names></name><name><surname>Bracken</surname><given-names>AP</given-names></name><name><surname>Jensen</surname><given-names>MR</given-names></name><name><surname>Lazzerini Denchi</surname><given-names>E</given-names></name><name><surname>Helin</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>4061</fpage><lpage>4071</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600402</pub-id><pub-id pub-id-type="pmid">15385962</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pini</surname><given-names>J</given-names></name><name><surname>Kueper</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>YD</given-names></name><name><surname>Kawasaki</surname><given-names>K</given-names></name><name><surname>Yeung</surname><given-names>P</given-names></name><name><surname>Tsimbal</surname><given-names>C</given-names></name><name><surname>Yoon</surname><given-names>B</given-names></name><name><surname>Carmichael</surname><given-names>N</given-names></name><name><surname>Maas</surname><given-names>RL</given-names></name><name><surname>Cotney</surname><given-names>J</given-names></name><name><surname>Grinblat</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ALX1-related frontonasal dysplasia results from defective neural crest cell development and migration</article-title><source>EMBO Molecular Medicine</source><volume>12</volume><elocation-id>e12013</elocation-id><pub-id pub-id-type="doi">10.15252/emmm.202012013</pub-id><pub-id pub-id-type="pmid">32914578</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piunti</surname><given-names>A</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The roles of Polycomb repressive complexes in mammalian development and cancer</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>22</volume><fpage>326</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/s41580-021-00341-1</pub-id><pub-id pub-id-type="pmid">33723438</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigueur</surname><given-names>D</given-names></name><name><surname>Lyons</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Skeletal development and repair, methods and protocols</article-title><source>Methods in Molecular Biology</source><volume>1130</volume><fpage>113</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1007/978-1-62703-989-5_9</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotllant</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Yan</surname><given-names>YL</given-names></name><name><surname>Postlethwait</surname><given-names>JH</given-names></name><name><surname>Westerfield</surname><given-names>M</given-names></name><name><surname>Du</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Sparc (Osteonectin) functions in morphogenesis of the pharyngeal skeleton and inner ear</article-title><source>Matrix Biology</source><volume>27</volume><fpage>561</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2008.03.001</pub-id><pub-id pub-id-type="pmid">18430553</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sandell</surname><given-names>L</given-names></name><name><surname>Inman</surname><given-names>K</given-names></name><name><surname>Trainor</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><source>DAPI Staining of Whole-Mount Mouse Embryos or Fetal Organs</source><publisher-name>Cold Spring Harb Protoc</publisher-name><pub-id pub-id-type="doi">10.1101/pdb.prot094029</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>A</given-names></name><name><surname>Faust</surname><given-names>C</given-names></name><name><surname>Magnuson</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Positional cloning of a global regulator of anterior–posterior patterning in mice</article-title><source>Nature</source><volume>383</volume><fpage>250</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1038/383250a0</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>D</given-names></name><name><surname>Varum</surname><given-names>S</given-names></name><name><surname>Zemke</surname><given-names>M</given-names></name><name><surname>Schöler</surname><given-names>A</given-names></name><name><surname>Baggiolini</surname><given-names>A</given-names></name><name><surname>Draganova</surname><given-names>K</given-names></name><name><surname>Koseki</surname><given-names>H</given-names></name><name><surname>Schübeler</surname><given-names>D</given-names></name><name><surname>Sommer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ezh2 is required for neural crest-derived cartilage and bone formation</article-title><source>Development</source><volume>141</volume><fpage>867</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1242/dev.094342</pub-id><pub-id pub-id-type="pmid">24496623</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sewalt</surname><given-names>RG</given-names></name><name><surname>van der Vlag</surname><given-names>J</given-names></name><name><surname>Gunster</surname><given-names>MJ</given-names></name><name><surname>Hamer</surname><given-names>KM</given-names></name><name><surname>den Blaauwen</surname><given-names>JL</given-names></name><name><surname>Satijn</surname><given-names>DP</given-names></name><name><surname>Hendrix</surname><given-names>T</given-names></name><name><surname>van Driel</surname><given-names>R</given-names></name><name><surname>Otte</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes</article-title><source>Molecular and Cellular Biology</source><volume>18</volume><fpage>3586</fpage><lpage>3595</lpage><pub-id pub-id-type="doi">10.1128/MCB.18.6.3586</pub-id><pub-id pub-id-type="pmid">9584199</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukunami</surname><given-names>C</given-names></name><name><surname>Takimoto</surname><given-names>A</given-names></name><name><surname>Oro</surname><given-names>M</given-names></name><name><surname>Hiraki</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes</article-title><source>Developmental Biology</source><volume>298</volume><fpage>234</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.06.036</pub-id><pub-id pub-id-type="pmid">16876153</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shull</surname><given-names>LC</given-names></name><name><surname>Sen</surname><given-names>R</given-names></name><name><surname>Menzel</surname><given-names>J</given-names></name><name><surname>Goyama</surname><given-names>S</given-names></name><name><surname>Kurokawa</surname><given-names>M</given-names></name><name><surname>Artinger</surname><given-names>KB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The conserved and divergent roles of Prdm3 and Prdm16 in zebrafish and mouse craniofacial development</article-title><source>Developmental Biology</source><volume>461</volume><fpage>132</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2020.02.006</pub-id><pub-id pub-id-type="pmid">32044379</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simões-Costa</surname><given-names>M</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Establishing neural crest identity: a gene regulatory recipe</article-title><source>Development</source><volume>142</volume><fpage>242</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1242/dev.105445</pub-id><pub-id pub-id-type="pmid">25564621</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smits</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Mandel</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>JM</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>de Crombrugghe</surname><given-names>B</given-names></name><name><surname>Lefebvre</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The transcription factors L-Sox5 and Sox6 are essential for cartilage formation</article-title><source>Developmental Cell</source><volume>1</volume><fpage>277</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/s1534-5807(01)00003-x</pub-id><pub-id pub-id-type="pmid">11702786</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spellicy</surname><given-names>CJ</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Olewiler</surname><given-names>L</given-names></name><name><surname>Cathey</surname><given-names>SS</given-names></name><name><surname>Rogers</surname><given-names>RC</given-names></name><name><surname>Bartholomew</surname><given-names>D</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Alexov</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>JA</given-names></name><name><surname>Friez</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Three additional patients with EED-associated overgrowth: potential mutation hotspots identified?</article-title><source>Journal of Human Genetics</source><volume>64</volume><fpage>561</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1038/s10038-019-0585-5</pub-id><pub-id pub-id-type="pmid">30858506</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamamura</surname><given-names>Y</given-names></name><name><surname>Katsube</surname><given-names>K</given-names></name><name><surname>Mera</surname><given-names>H</given-names></name><name><surname>Itokazu</surname><given-names>M</given-names></name><name><surname>Wakitani</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Irx3 and Bmp2 regulate mouse mesenchymal cell chondrogenic differentiation in both a Sox9-dependent and -independent manner</article-title><source>Journal of Cellular Physiology</source><volume>232</volume><fpage>3317</fpage><lpage>3336</lpage><pub-id pub-id-type="doi">10.1002/jcp.25776</pub-id><pub-id pub-id-type="pmid">28059449</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Kong</surname><given-names>M</given-names></name><name><surname>Wen</surname><given-names>S</given-names></name><name><surname>Tsang</surname><given-names>KY</given-names></name><name><surname>Niu</surname><given-names>B</given-names></name><name><surname>Hartmann</surname><given-names>C</given-names></name><name><surname>Chan</surname><given-names>D</given-names></name><name><surname>Hui</surname><given-names>C-C</given-names></name><name><surname>Cheah</surname><given-names>KSE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>IRX3 and IRX5 inhibit adipogenic differentiation of hypertrophic chondrocytes and promote osteogenesis</article-title><source>Journal of Bone and Mineral Research</source><volume>35</volume><fpage>2444</fpage><lpage>2457</lpage><pub-id pub-id-type="doi">10.1002/jbmr.4132</pub-id><pub-id pub-id-type="pmid">32662900</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatton-Brown</surname><given-names>K</given-names></name><name><surname>Murray</surname><given-names>A</given-names></name><name><surname>Hanks</surname><given-names>S</given-names></name><name><surname>Douglas</surname><given-names>J</given-names></name><name><surname>Armstrong</surname><given-names>R</given-names></name><name><surname>Banka</surname><given-names>S</given-names></name><name><surname>Bird</surname><given-names>LM</given-names></name><name><surname>Clericuzio</surname><given-names>CL</given-names></name><name><surname>Cormier-Daire</surname><given-names>V</given-names></name><name><surname>Cushing</surname><given-names>T</given-names></name><name><surname>Flinter</surname><given-names>F</given-names></name><name><surname>Jacquemont</surname><given-names>M-L</given-names></name><name><surname>Joss</surname><given-names>S</given-names></name><name><surname>Kinning</surname><given-names>E</given-names></name><name><surname>Lynch</surname><given-names>SA</given-names></name><name><surname>Magee</surname><given-names>A</given-names></name><name><surname>McConnell</surname><given-names>V</given-names></name><name><surname>Medeira</surname><given-names>A</given-names></name><name><surname>Ozono</surname><given-names>K</given-names></name><name><surname>Patton</surname><given-names>M</given-names></name><name><surname>Rankin</surname><given-names>J</given-names></name><name><surname>Shears</surname><given-names>D</given-names></name><name><surname>Simon</surname><given-names>M</given-names></name><name><surname>Splitt</surname><given-names>M</given-names></name><name><surname>Strenger</surname><given-names>V</given-names></name><name><surname>Stuurman</surname><given-names>K</given-names></name><name><surname>Taylor</surname><given-names>C</given-names></name><name><surname>Titheradge</surname><given-names>H</given-names></name><name><surname>Van Maldergem</surname><given-names>L</given-names></name><name><surname>Temple</surname><given-names>IK</given-names></name><name><surname>Cole</surname><given-names>T</given-names></name><name><surname>Seal</surname><given-names>S</given-names></name><collab>Childhood Overgrowth Consortium</collab><name><surname>Rahman</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype</article-title><source>American Journal of Medical Genetics. Part A</source><volume>161A</volume><fpage>2972</fpage><lpage>2980</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.36229</pub-id><pub-id pub-id-type="pmid">24214728</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tien</surname><given-names>CL</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Gerigk</surname><given-names>M</given-names></name><name><surname>Nozell</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Snail2/Slug cooperates with Polycomb repressive complex 2 (PRC2) to regulate neural crest development</article-title><source>Development</source><volume>142</volume><fpage>722</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1242/dev.111997</pub-id><pub-id pub-id-type="pmid">25617436</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Otterloo</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>KL</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>AP-2α and AP-2β cooperatively orchestrate homeobox gene expression during branchial arch patterning</article-title><source>Development</source><volume>145</volume><elocation-id>dev157438</elocation-id><pub-id pub-id-type="doi">10.1242/dev.157438</pub-id><pub-id pub-id-type="pmid">29229773</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Otterloo</surname><given-names>E</given-names></name><name><surname>Milanda</surname><given-names>I</given-names></name><name><surname>Pike</surname><given-names>H</given-names></name><name><surname>Thompson</surname><given-names>JA</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>KL</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>AP-2α and AP-2β cooperatively function in the craniofacial surface ectoderm to regulate chromatin and gene expression dynamics during facial development</article-title><source>eLife</source><volume>11</volume><elocation-id>e70511</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.70511</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whyte</surname><given-names>WA</given-names></name><name><surname>Orlando</surname><given-names>DA</given-names></name><name><surname>Hnisz</surname><given-names>D</given-names></name><name><surname>Abraham</surname><given-names>BJ</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Kagey</surname><given-names>MH</given-names></name><name><surname>Rahl</surname><given-names>PB</given-names></name><name><surname>Lee</surname><given-names>TI</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Master transcription factors and mediator establish super-enhancers at key cell identity genes</article-title><source>Cell</source><volume>153</volume><fpage>307</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.03.035</pub-id><pub-id pub-id-type="pmid">23582322</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Balczerski</surname><given-names>B</given-names></name><name><surname>Ciozda</surname><given-names>A</given-names></name><name><surname>Louie</surname><given-names>K</given-names></name><name><surname>Oralova</surname><given-names>V</given-names></name><name><surname>Huysseune</surname><given-names>A</given-names></name><name><surname>Crump</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fox proteins are modular competency factors for facial cartilage and tooth specification</article-title><source>Development</source><volume>145</volume><elocation-id>dev165498</elocation-id><pub-id pub-id-type="doi">10.1242/dev.165498</pub-id><pub-id pub-id-type="pmid">29777011</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>YL</given-names></name><name><surname>Miller</surname><given-names>CT</given-names></name><name><surname>Nissen</surname><given-names>RM</given-names></name><name><surname>Singer</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Kirn</surname><given-names>A</given-names></name><name><surname>Draper</surname><given-names>B</given-names></name><name><surname>Willoughby</surname><given-names>J</given-names></name><name><surname>Morcos</surname><given-names>PA</given-names></name><name><surname>Amsterdam</surname><given-names>A</given-names></name><name><surname>Chung</surname><given-names>BC</given-names></name><name><surname>Westerfield</surname><given-names>M</given-names></name><name><surname>Haffter</surname><given-names>P</given-names></name><name><surname>Hopkins</surname><given-names>N</given-names></name><name><surname>Kimmel</surname><given-names>C</given-names></name><name><surname>Postlethwait</surname><given-names>JH</given-names></name><name><surname>Nissen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A zebrafish sox9 gene required for cartilage morphogenesis</article-title><source>Development</source><volume>129</volume><fpage>5065</fpage><lpage>5079</lpage><pub-id pub-id-type="doi">10.1242/dev.129.21.5065</pub-id><pub-id pub-id-type="pmid">12397114</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Riva</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Schindler</surname><given-names>Y</given-names></name><name><surname>Moran</surname><given-names>TB</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Hardison</surname><given-names>R</given-names></name><name><surname>Weiss</surname><given-names>MJ</given-names></name><name><surname>Orkin</surname><given-names>SH</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Fraenkel</surname><given-names>E</given-names></name><name><surname>Cantor</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis</article-title><source>Molecular Cell</source><volume>36</volume><fpage>682</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2009.11.002</pub-id><pub-id pub-id-type="pmid">19941827</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100159.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Di</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Chinese Academy of Sciences</institution><country>China</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>In this <bold>valuable</bold> study, the authors used an elegant genetic approach to delete EED at the post-neural crest induction stage. The usage of the single-cell RNA-seq analysis method is extremely suitable to determine changes in the cell type-specific gene expression during development. Results backed by <bold>solid</bold> evidence demonstrate that Eed is required for craniofacial osteoblast differentiation and mesenchymal proliferation after the induction of the neural crest.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100159.3.sa1</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The role of PRC2 in post neural crest induction was not well understood. This work developed an elegant mouse genetic system to conditionally deplete EED upon SOX10 activation. Substantial developmental defects were identified for craniofacial and bone development. The authors also performed extensive single-cell RNA sequencing to analyze differentiation gene expression changes upon conditional EED disruption.</p><p>Strengths:</p><p>(1) Elegant genetic system to ablate EED post neural crest induction.</p><p>(2) Single-cell RNA-seq analysis is extremely suitable for studying the cell type specific gene expression changes in developmental systems.</p><p>Original Weaknesses:</p><p>(1) Although this study is well designed and contains state-of-art single cell RNA-seq analysis, it lacks the mechanistic depth in the EED/PRC2-mediated epigenetic repression. This is largely because no epigenomic data was shown.</p><p>(2) The mouse model of conditional loss of EZH2 in neural crest has been previously reported, as the authors pointed out in the discussion. What is novelty in this study to disrupt EED? Perhaps a more detailed comparison of the two mouse models would be beneficial.</p><p>(3) The presentation of the single-cell RNA-seq data may need improvement. The complexity of the many cell types blurs the importance of which cell types are affected the most by EED disruption.</p><p>(4) While it's easy to identify PRC2/EED target genes using published epigenomic data, it would be nice to tease out the direct versus indirect effects in the gene expression changes (e.g Fig. 4e)</p><p>Comments on latest version:</p><p>The authors have addressed weaknesses 2 and 3 of my previous comment very well. For weaknesses 1 and 4, the authors have added a main Fig 5 and its associated supplemental materials, which definitely strengthen the mechanistic depth of the story. However, I think the audience would appreciate if the following questions/points could be further addressed regarding the Cut&amp;Tag data (mostly related to main Figure 5):</p><p>(1) The authors described that Sox10-Cre would be expressed at E8.75, and in theory, EED-FL would be ablated soon after that. Why would E16.5 exhibit a much smaller loss in H3K27me3 compared to E12.5? Shouldn't a prolong loss of EED lead to even worse consequence?</p><p>(2) The gene expression change at E12.5 upon loss of EED (shown in Fig. 4h) seems to be massive, including many PRC2-target genes. However, the H3K27me3 alteration seems to be mild even at E12.5. Does this infer a PRC2 or H3K27 methylation - independent role of EED? To address this, I suggest the authors re-consider addressing my previously commented weakness #4 regarding the RNA-seq versus Cut&amp;Tag change correlation. For example, a gene scatter plot with X-axis of RNA-seq changes versus Y-axis of H3K27me3 level changes.</p><p>(3) The CUT&amp;Tag experiments seem to contain replicates according to the figure legend, but no statistical analysis was presented including the new supplemental tables. Also, for Fig. 5c-d, instead of showing the MRR in individual conditions, I think the audience would really want to know the differential MRR between Fl/WT and Fl/Fl. In other words, how many genes/ MRR have statistically lower H3K27me3 level upon EED loss.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100159.3.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Casey-Clyde</surname><given-names>Tim</given-names></name><role specific-use="author">Author</role><aff><institution>UCSF Helen Diller Family Comprehensive Cancer Center</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>S John</given-names></name><role specific-use="author">Author</role><aff><institution>UCSF Helen Diller Family Comprehensive Cancer Center</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Pelonero</surname><given-names>Angelo</given-names></name><role specific-use="author">Author</role><aff><institution>UCSF</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Serrano</surname><given-names>Juan Antonio Camara</given-names></name><role specific-use="author">Author</role><aff><institution>UCSF Helen Diller Family Comprehensive Cancer Center</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Teng</surname><given-names>Camilla</given-names></name><role specific-use="author">Author</role><aff><institution>University of California San Francisco Medical Center</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Jang</surname><given-names>Yoon-Gu</given-names></name><role specific-use="author">Author</role><aff><institution>University of California San Francisco Medical Center</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Vasudevan</surname><given-names>Harish N</given-names></name><role specific-use="author">Author</role><aff><institution>UCSF Helen Diller Family Comprehensive Cancer Center</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Padmanabhan</surname><given-names>Arun</given-names></name><role specific-use="author">Author</role><aff><institution>UCSF Helen Diller Family Comprehensive Cancer Center</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Bush</surname><given-names>Jeffrey Ohmann</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Raleigh</surname><given-names>David R</given-names></name><role specific-use="author">Author</role><aff><institution>UCSF Helen Diller Family Comprehensive Cancer Center</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review):</bold></p><p>Epigenetic regulation complex (PRC2) is essential for neural crest specification, and its misregulation has been shown to cause severe craniofacial defects. This study shows that Eed, a core PRC2 component, is critical for craniofacial osteoblast differentiation and mesenchymal proliferation after neural crest induction. Using mouse genetics and single-cell RNA sequencing, the researcher found that conditional knockout of Eed leads to significant craniofacial hypoplasia, impaired osteogenesis, and reduced proliferation of mesenchymal cells in post-migratory neural crest populations.</p><p>Overall, the study is superficial and descriptive. No in-depth mechanism was analyzed and the phenotype analysis is not comprehensive.</p></disp-quote><p>We thank the reviewer for sharing their expertise and for taking the time to provide helpful suggestions to improve our study. We are gratified that the striking phenotypes we report from Eed loss in post-migratory neural crest craniofacial tissues were appreciated. The breadth and depth of our phenotyping techniques, including skeletal staining, micro-CT, echocardiogram, immunofluorescence, histology, and primary craniofacial cell culture provide comprehensive data in support our hypothesis that PRC2 is required for epigenetic control of craniofacial osteoblast differentiation. To provide mechanistic data in support of this hypothesis, we have now performed CUT&amp;Tag H3K27me3 chromatin profiling on nuclei harvested from E12.5 or E16.5 Sox10-Cre Eed<sup>Fl/WT</sup> and Sox10-Cre Eed<sup>Fl/Fl</sup> craniofacial tissue. These new data, which are presented in Fig. 5, Supplementary Fig. 9, and Supplementary Tables 7-10 of our revised manuscript, validate our hypothesis that epigenetic regulation of chromatin architecture downstream of PRC2 activity underlies craniofacial osteoblast differentiation. In particular, we now show that Eed-dependent H3K27me3 methylation is associated with correct temporal expression of transcription factors that are necessary for craniofacial differentiation and patterning, such as including Msx1, Pitx1, Pax7, which were initially nominated by single-cell RNA sequencing of E12.5 Sox10-Cre Eed<sup>Fl/WT</sup> and Sox10-Cre Eed<sup>Fl/Fl</sup> craniofacial tissues in Fig. 4, Supplementary Fig. 5-7, and Supplementary Tables 1-6.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>The role of PRC2 in post-neural crest induction was not well understood. This work developed an elegant mouse genetic system to conditionally deplete EED upon SOX10 activation. Substantial developmental defects were identified for craniofacial and bone development. The authors also performed extensive single-cell RNA sequencing to analyze differentiation gene expression changes upon conditional EED disruption.</p><p>Strengths:</p><p>(1) Elegant genetic system to ablate EED post neural crest induction.</p><p>(2) Single-cell RNA-seq analysis is extremely suitable for studying the cell type-specific gene expression changes in developmental systems.</p></disp-quote><p>We thank the reviewer for their generous and helpful comments on our study. We are happy that our mouse genetic and single-cell RNA sequencing approaches were appropriate in pairing the craniofacial phenotypes we report with distinct gene expression changes in post-migratory neural crest tissues upon Eed deletion.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>(1) Although this study is well designed and contains state-of-the-art single-cell RNA-seq analysis, it lacks the mechanistic depth in the EED/PRC2-mediated epigenetic repression. This is largely because no epigenomic data was shown.</p></disp-quote><p>Thank you for this suggestion. As described in response to Reviewer #1, we have now performed CUT&amp;Tag H3K27me3 chromatin profiling on nuclei harvested from E12.5 or E16.5 Sox10-Cre Eed<sup>Fl/WT</sup> and Sox10-Cre Eed<sup>Fl/Fl</sup> craniofacial tissues to provide mechanistic epigenomic data in support of our hypothesis that hat PRC2 is required for craniofacial osteoblast differentiation. These new data, which are presented in Fig. 5, Supplementary Fig. 9, and Supplementary Tables 7-10 of our revised manuscript, integrate genome-wide and targeted metaplot visualizations across genotypes with in-depth analyses of methylation rich regions and genes associated with methylation rich loci. Broadly, these new data reveal that changes in H3K27me3 occupancy correlate with gene expression changes from single-cell RNA sequencing of E12.5 Sox10-Cre Eed<sup>Fl/WT</sup> and Sox10-Cre Eed<sup>Fl/Fl</sup> craniofacial tissues in Fig. 4, Supplementary Fig. 5-7, and Supplementary Tables 1-6.</p><disp-quote content-type="editor-comment"><p>(2) The mouse model of conditional loss of EZH2 in neural crest has been previously reported, as the authors pointed out in the discussion. What is novel in this study to disrupt EED? Perhaps a more detailed comparison of the two mouse models would be beneficial.</p></disp-quote><p>We acknowledge and cite the study the reviewer has indicated (Schwarz et al. Development 2014) in our initial and revised manuscripts. This elegant investigation uses Wnt1-Cre to delete Ezh2 and reports a phenotype similar to the one we observed with Sox10-Cre deletion of Eed, but our study adds depth to the understanding of PRC2’s vital role in neural crest development by ablating Eed, which has a unique function in the PRC2 complex by binding to H3K27me3 and allosterically activating Ezh2. In this sense, our study sheds light on whether phenotypes arising from deletion of Eed, the PRC2 “reader”, differ from phenotypes arising from deletion of Ezh2, the PRC2 “writer”, in neural crest derived tissues. Moreover, we provide the first single-cell RNA sequencing and epigenomic investigations of craniofacial phenotypes arising from PRC2 activity in the developing neural crest. Due to limitations associated with the Wnt1-Cre transgene (Lewis et al. Developmental Biology 2013), which targets pre-migratory neural crest cells, our investigations used Sox10Cre, which targets the migratory neural crest and is completely recombined by E10.5. We have included a detailed comparison of these mouse models in the Discussion section of our revised manuscript, and we thank the reviewer for this thoughtful suggestion.</p><disp-quote content-type="editor-comment"><p>(3) The presentation of the single-cell RNA-seq data may need improvement. The complexity of the many cell types blurs the importance of which cell types are affected the most by EED disruption.</p></disp-quote><p>We thank the reviewer for the opportunity to improve the presentation of our single-cell RNA sequencing data. In response, we have added Supplementary Fig. 8 to our revised manuscript, which shows the cell clusters most affected by EED disruption in UMAP space across genotypes. Because we wanted to capture the fill diversity of cell types underlying the phenotypes we report, we did not sort Sox10+ cells (via FACS, for example) from craniofacial tissues before single-cell RNA sequencing. Our resulting single-cell RNA sequencing data are therefore inclusive of a diversity of cell types in UMAP space, and the prevalence of many of these cell types was unaffected by epigenetic disruption of neural crest derived tissues. The prevalence of the cell clusters that are most affected across genotypes and which are most relevant to our analyses of the developing neural crest are shown in Fig. 4c (and now also in Supplementary Fig. 8), including C0 (differentiating osteoblasts), C4 (mesenchymal stem cells), C5 (mesenchymal stem cells), and C7 (proliferating mesenchymal stem cells). Marker genes and pseudobulked differential expression analyses across these clusters are shown in Fig. 4d and Fig. 4e-h, respectively.</p><disp-quote content-type="editor-comment"><p>(4) While it's easy to identify PRC2/EED target genes using published epigenomic data, it would be nice to tease out the direct versus indirect effects in the gene expression changes (e.g Figure 4e).</p></disp-quote><p>We agree with the reviewer that the single-cell RNA sequencing data in our initial submission do not provide insight into direct versus indirect changes in gene expression downstream of PRC2. In contrast, the CUT&amp;Tag chromatin profiling data that we have generated for this revision provides mechanistic insight into H3K27me3 occupancy and direct effects on gene expression resulting from PRC2 inactivation in our mouse models.</p><disp-quote content-type="editor-comment"><p><bold>Reviewing editor comments:</bold></p><p>The following are recommended as essential revisions</p><p>(1) The study is overall superficial and primarily descriptive, lacking in-depth mechanistic analysis and comprehensive phenotype evaluation.</p></disp-quote><p>Please see responses to Reviewer #1 and Reviewer #2 (weaknesses 1 and 4) above.</p><disp-quote content-type="editor-comment"><p>(2) The authors did not investigate the temporal and spatial expression of Eed during cranial neural crest development, which is crucial for explaining the observed phenotypes.</p></disp-quote><p>The temporal and spatial expression of Eed during embryogenesis is well studied. Eed is ubiquitously expressed starting at E5.5, peaks at E9.5, and is downregulated but maintained at a high basal expression level through E18.5 (Schumacher et al. Nature 1996). Although comprehensive analysis of Eed expression in neural crest tissues has not been reported (to our knowledge), Eed physically and functionally interacts with Ezh2 (Sewalt et al. Mol Cell Biol 1998), which is enriched at a diversity of timepoints throughout all developing craniofacial tissues (Schwarz et al. Development 2014). In our study, we confirmed enrichment of Eed expression in craniofacial tissues throughout development using QPCR, and have provided a more detailed description of these published and new findings in the Discussion section of our revised manuscript.</p><disp-quote content-type="editor-comment"><p>(3) There is no apoptosis analysis provided for any of the samples.</p></disp-quote><p>We evaluated the presence of apoptotic cells in E12.5 craniofacial sections using immunofluorescence for Cleaved Caspase 3 in Supplementary Fig. 3d. Although we found a modest increase in the labeling index of apoptotic cells, there was insufficient evidence to conclude that apoptosis is a substantial factor in craniofacial hypoplasia resulting from Eed loss in post-migratory neural crest craniofacial tissues. We have clarified these findings in the Results and Discussion sections of our revised manuscript.</p><disp-quote content-type="editor-comment"><p>(4) As Eed is a core component of the PRC2 complex, were any other components altered in the Eed cKO mutant? How does Eed regulation influence osteogenic differentiation and proliferation through known pathways?</p></disp-quote><p>We thank the editors for this thoughtful inquiry. Although we did not specifically investigate expression or stability of other PRC2 components in Eed conditional mutants, and little is known about how Eed regulates osteogenic differentiation or proliferation through any pathway, our single-cell RNA sequencing data presented in Fig. 4, Supplementary Fig. 5-7, and Supplementary Tables 1-6 provide a significant conceptual advance with mechanistic implications for understanding bone development downstream of Eed and do not reveal any alterations in the expression of other PRC2 components across genotypes. We have clarified these important details in the Discussion section of our revised manuscript.</p><disp-quote content-type="editor-comment"><p>(5) The authors may compare the Eed cKO phenotype with that of the previous EZH2 cKO mouse model since both Eed and EZH2 are essential subunits of PRC2.</p></disp-quote><p>Please see responses to editorial comment 2 above and the last paragraph of the Discussion section of our revised manuscript for comparisons between Eed and Ezh2 knockout phenotypes.</p></body></sub-article></article>